| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exome | 79 | 2023 | 1042 | 4.180 |
Why?
|
| Sequence Analysis, DNA | 109 | 2021 | 1761 | 4.040 |
Why?
|
| Mutation | 108 | 2024 | 5812 | 3.260 |
Why?
|
| Genetic Variation | 64 | 2021 | 1493 | 2.940 |
Why?
|
| High-Throughput Nucleotide Sequencing | 46 | 2024 | 869 | 2.790 |
Why?
|
| Genome | 38 | 2022 | 476 | 2.410 |
Why?
|
| Genomics | 57 | 2023 | 1491 | 2.390 |
Why?
|
| Polymorphism, Single Nucleotide | 75 | 2024 | 2625 | 2.160 |
Why?
|
| Genetic Predisposition to Disease | 55 | 2024 | 3142 | 2.100 |
Why?
|
| Genome, Human | 40 | 2024 | 1273 | 2.050 |
Why?
|
| DNA Copy Number Variations | 32 | 2024 | 943 | 1.910 |
Why?
|
| Evolution, Molecular | 36 | 2020 | 675 | 1.850 |
Why?
|
| Genetic Diseases, Inborn | 17 | 2019 | 446 | 1.570 |
Why?
|
| Alleles | 34 | 2024 | 1618 | 1.550 |
Why?
|
| Pedigree | 57 | 2023 | 1596 | 1.520 |
Why?
|
| Phenotype | 54 | 2024 | 4261 | 1.510 |
Why?
|
| Whole Genome Sequencing | 18 | 2023 | 280 | 1.390 |
Why?
|
| Genome, Insect | 11 | 2020 | 96 | 1.270 |
Why?
|
| Genetic Association Studies | 31 | 2021 | 777 | 1.270 |
Why?
|
| Humans | 341 | 2025 | 124797 | 1.220 |
Why?
|
| Mutation, Missense | 21 | 2023 | 868 | 1.130 |
Why?
|
| Intellectual Disability | 15 | 2023 | 1061 | 1.090 |
Why?
|
| Genetic Testing | 17 | 2024 | 1004 | 1.080 |
Why?
|
| Exons | 26 | 2020 | 796 | 1.070 |
Why?
|
| Male | 184 | 2025 | 61285 | 1.000 |
Why?
|
| Female | 185 | 2025 | 66555 | 0.960 |
Why?
|
| Membrane Proteins | 20 | 2023 | 1527 | 0.960 |
Why?
|
| Phylogeny | 28 | 2020 | 696 | 0.930 |
Why?
|
| Clinical Laboratory Services | 1 | 2024 | 19 | 0.890 |
Why?
|
| Genome-Wide Association Study | 26 | 2021 | 1674 | 0.890 |
Why?
|
| Germ-Line Mutation | 10 | 2025 | 333 | 0.880 |
Why?
|
| Urogenital Abnormalities | 6 | 2023 | 156 | 0.830 |
Why?
|
| Craniofacial Abnormalities | 7 | 2022 | 242 | 0.820 |
Why?
|
| Molecular Sequence Data | 58 | 2016 | 3881 | 0.790 |
Why?
|
| Homozygote | 17 | 2024 | 534 | 0.790 |
Why?
|
| Animals | 123 | 2024 | 34186 | 0.770 |
Why?
|
| Adaptor Proteins, Signal Transducing | 9 | 2025 | 537 | 0.760 |
Why?
|
| Abnormalities, Multiple | 11 | 2022 | 963 | 0.750 |
Why?
|
| Muscle Hypotonia | 7 | 2019 | 188 | 0.750 |
Why?
|
| Software | 15 | 2024 | 686 | 0.720 |
Why?
|
| Limb Deformities, Congenital | 5 | 2022 | 106 | 0.710 |
Why?
|
| Gene Frequency | 21 | 2021 | 719 | 0.710 |
Why?
|
| Genotype | 26 | 2024 | 2557 | 0.710 |
Why?
|
| Dwarfism | 5 | 2022 | 100 | 0.700 |
Why?
|
| Macaca mulatta | 9 | 2020 | 492 | 0.680 |
Why?
|
| Genome, Bacterial | 11 | 2017 | 186 | 0.680 |
Why?
|
| Base Sequence | 44 | 2022 | 3099 | 0.680 |
Why?
|
| Transcription Factors | 17 | 2025 | 2610 | 0.670 |
Why?
|
| Frameshift Mutation | 10 | 2023 | 180 | 0.670 |
Why?
|
| INDEL Mutation | 9 | 2022 | 87 | 0.650 |
Why?
|
| Open Reading Frames | 13 | 2021 | 209 | 0.640 |
Why?
|
| Brain Neoplasms | 9 | 2023 | 1243 | 0.630 |
Why?
|
| Biological Evolution | 9 | 2020 | 224 | 0.620 |
Why?
|
| Genetic Loci | 8 | 2021 | 339 | 0.620 |
Why?
|
| Molecular Sequence Annotation | 12 | 2021 | 149 | 0.620 |
Why?
|
| Transcriptome | 10 | 2022 | 938 | 0.620 |
Why?
|
| Computational Biology | 19 | 2021 | 821 | 0.600 |
Why?
|
| Child | 70 | 2025 | 24454 | 0.600 |
Why?
|
| Child, Preschool | 54 | 2024 | 14050 | 0.590 |
Why?
|
| Repressor Proteins | 9 | 2019 | 820 | 0.580 |
Why?
|
| Pharmacogenetics | 4 | 2022 | 184 | 0.560 |
Why?
|
| Databases, Genetic | 15 | 2021 | 473 | 0.560 |
Why?
|
| Anodontia | 4 | 2018 | 30 | 0.550 |
Why?
|
| Proteins | 13 | 2018 | 1046 | 0.540 |
Why?
|
| Charcot-Marie-Tooth Disease | 6 | 2015 | 199 | 0.530 |
Why?
|
| Heterozygote | 18 | 2020 | 676 | 0.530 |
Why?
|
| DNA Mutational Analysis | 17 | 2021 | 791 | 0.520 |
Why?
|
| DNA-Binding Proteins | 14 | 2023 | 2059 | 0.520 |
Why?
|
| Immunologic Deficiency Syndromes | 5 | 2020 | 205 | 0.520 |
Why?
|
| Insect Proteins | 6 | 2020 | 99 | 0.510 |
Why?
|
| Aging | 8 | 2016 | 1189 | 0.500 |
Why?
|
| Cohort Studies | 27 | 2024 | 4783 | 0.490 |
Why?
|
| Gene Expression Regulation | 13 | 2021 | 2538 | 0.490 |
Why?
|
| Haplotypes | 10 | 2024 | 520 | 0.490 |
Why?
|
| Killer Cells, Natural | 4 | 2020 | 324 | 0.490 |
Why?
|
| Adult | 63 | 2025 | 29472 | 0.480 |
Why?
|
| Musculoskeletal Abnormalities | 3 | 2022 | 72 | 0.480 |
Why?
|
| Genes, Insect | 7 | 2015 | 123 | 0.480 |
Why?
|
| Heart Diseases | 6 | 2014 | 494 | 0.480 |
Why?
|
| Gene Regulatory Networks | 4 | 2020 | 355 | 0.470 |
Why?
|
| Growth Disorders | 4 | 2018 | 210 | 0.460 |
Why?
|
| Genetic Markers | 5 | 2020 | 606 | 0.460 |
Why?
|
| Gene Expression Profiling | 13 | 2021 | 1697 | 0.460 |
Why?
|
| DNA, Bacterial | 8 | 2017 | 474 | 0.450 |
Why?
|
| Infant | 38 | 2021 | 12483 | 0.450 |
Why?
|
| Arthropods | 4 | 2020 | 26 | 0.450 |
Why?
|
| Biomarkers, Tumor | 5 | 2023 | 1465 | 0.440 |
Why?
|
| Mammals | 5 | 2015 | 260 | 0.440 |
Why?
|
| Drosophila melanogaster | 10 | 2016 | 770 | 0.440 |
Why?
|
| Glioma | 4 | 2023 | 500 | 0.430 |
Why?
|
| Synteny | 12 | 2017 | 74 | 0.430 |
Why?
|
| Genetic Heterogeneity | 6 | 2024 | 123 | 0.430 |
Why?
|
| Amino Acid Sequence | 27 | 2020 | 2704 | 0.430 |
Why?
|
| Nuclear Proteins | 9 | 2020 | 1272 | 0.420 |
Why?
|
| Nervous System Diseases | 4 | 2019 | 376 | 0.420 |
Why?
|
| Adolescent | 46 | 2021 | 19329 | 0.420 |
Why?
|
| Carrier Proteins | 8 | 2023 | 1026 | 0.410 |
Why?
|
| Chromosome Mapping | 16 | 2017 | 1082 | 0.410 |
Why?
|
| Microfilament Proteins | 6 | 2018 | 273 | 0.410 |
Why?
|
| Gene Dosage | 10 | 2020 | 441 | 0.400 |
Why?
|
| Megalencephaly | 3 | 2018 | 58 | 0.400 |
Why?
|
| Young Adult | 31 | 2021 | 8987 | 0.400 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 3 | 2022 | 36 | 0.400 |
Why?
|
| Multigene Family | 13 | 2020 | 297 | 0.400 |
Why?
|
| Heterotaxy Syndrome | 3 | 2024 | 61 | 0.400 |
Why?
|
| Developmental Disabilities | 6 | 2021 | 709 | 0.390 |
Why?
|
| Cell Cycle Proteins | 8 | 2020 | 647 | 0.390 |
Why?
|
| Mutation Rate | 6 | 2020 | 66 | 0.390 |
Why?
|
| Y Chromosome | 3 | 2020 | 47 | 0.390 |
Why?
|
| Microcephaly | 5 | 2023 | 332 | 0.390 |
Why?
|
| X Chromosome | 11 | 2020 | 337 | 0.380 |
Why?
|
| Chromosomes, Human, X | 6 | 2021 | 157 | 0.380 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2022 | 506 | 0.370 |
Why?
|
| Selection, Genetic | 13 | 2020 | 155 | 0.370 |
Why?
|
| Heart Defects, Congenital | 6 | 2024 | 1813 | 0.360 |
Why?
|
| Codon, Nonsense | 7 | 2020 | 132 | 0.360 |
Why?
|
| Meningioma | 2 | 2025 | 120 | 0.360 |
Why?
|
| Family | 8 | 2020 | 565 | 0.360 |
Why?
|
| DEAD-box RNA Helicases | 3 | 2022 | 121 | 0.360 |
Why?
|
| Genetics, Population | 10 | 2021 | 187 | 0.360 |
Why?
|
| Schizophrenia | 3 | 2020 | 302 | 0.360 |
Why?
|
| DNA, Complementary | 9 | 2021 | 464 | 0.360 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2018 | 551 | 0.360 |
Why?
|
| Micrognathism | 3 | 2016 | 66 | 0.360 |
Why?
|
| Meningeal Neoplasms | 2 | 2025 | 185 | 0.350 |
Why?
|
| Pancreatic Neoplasms | 4 | 2021 | 687 | 0.350 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2020 | 554 | 0.350 |
Why?
|
| Oxidoreductases | 4 | 2020 | 93 | 0.350 |
Why?
|
| Host-Parasite Interactions | 4 | 2020 | 70 | 0.350 |
Why?
|
| Middle Aged | 41 | 2025 | 26717 | 0.350 |
Why?
|
| TOR Serine-Threonine Kinases | 6 | 2023 | 428 | 0.340 |
Why?
|
| Gene Library | 14 | 2015 | 218 | 0.340 |
Why?
|
| Lipoprotein(a) | 2 | 2024 | 122 | 0.340 |
Why?
|
| Rhabdomyosarcoma | 2 | 2024 | 200 | 0.330 |
Why?
|
| Genomic Instability | 3 | 2022 | 229 | 0.330 |
Why?
|
| Social Behavior | 4 | 2020 | 209 | 0.330 |
Why?
|
| Fasting | 4 | 2016 | 302 | 0.330 |
Why?
|
| Genetic Linkage | 6 | 2019 | 453 | 0.330 |
Why?
|
| Primates | 3 | 2020 | 80 | 0.330 |
Why?
|
| Neoplasm Proteins | 4 | 2019 | 670 | 0.330 |
Why?
|
| Insecticide Resistance | 3 | 2020 | 29 | 0.330 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 3 | 2024 | 309 | 0.320 |
Why?
|
| Heteroptera | 2 | 2020 | 13 | 0.320 |
Why?
|
| Sequence Alignment | 15 | 2015 | 626 | 0.320 |
Why?
|
| Lymphoproliferative Disorders | 2 | 2021 | 224 | 0.320 |
Why?
|
| Cell Adhesion Molecules | 4 | 2018 | 224 | 0.310 |
Why?
|
| Actins | 3 | 2020 | 342 | 0.310 |
Why?
|
| Smith-Magenis Syndrome | 3 | 2019 | 105 | 0.310 |
Why?
|
| Atherosclerosis | 4 | 2019 | 910 | 0.310 |
Why?
|
| Genes, Recessive | 7 | 2022 | 179 | 0.310 |
Why?
|
| GTP Phosphohydrolases | 4 | 2019 | 144 | 0.310 |
Why?
|
| Coatomer Protein | 2 | 2021 | 30 | 0.310 |
Why?
|
| Quantitative Trait Loci | 9 | 2020 | 284 | 0.310 |
Why?
|
| Models, Genetic | 11 | 2020 | 759 | 0.310 |
Why?
|
| Cheirogaleidae | 2 | 2018 | 6 | 0.300 |
Why?
|
| DNA Methylation | 8 | 2021 | 1004 | 0.300 |
Why?
|
| Polymorphism, Genetic | 8 | 2019 | 812 | 0.300 |
Why?
|
| Mosaicism | 3 | 2020 | 241 | 0.300 |
Why?
|
| Cardiovascular Diseases | 5 | 2024 | 1943 | 0.300 |
Why?
|
| Comparative Genomic Hybridization | 9 | 2024 | 573 | 0.300 |
Why?
|
| Gene Duplication | 8 | 2024 | 358 | 0.300 |
Why?
|
| Metagenomics | 4 | 2017 | 102 | 0.300 |
Why?
|
| Biliary Atresia | 2 | 2023 | 190 | 0.300 |
Why?
|
| Metalloendopeptidases | 3 | 2017 | 100 | 0.300 |
Why?
|
| Genome, Protozoan | 2 | 2020 | 26 | 0.300 |
Why?
|
| Lipids | 2 | 2021 | 515 | 0.300 |
Why?
|
| Chromosome Aberrations | 4 | 2019 | 620 | 0.290 |
Why?
|
| Mice | 38 | 2023 | 17748 | 0.290 |
Why?
|
| Mitochondrial Proteins | 4 | 2017 | 237 | 0.290 |
Why?
|
| Genes, Dominant | 5 | 2020 | 247 | 0.290 |
Why?
|
| Chromosomes, Mammalian | 4 | 2022 | 41 | 0.290 |
Why?
|
| Chromosome Disorders | 3 | 2019 | 312 | 0.290 |
Why?
|
| Arthrogryposis | 2 | 2019 | 35 | 0.290 |
Why?
|
| Zebrafish | 11 | 2021 | 388 | 0.280 |
Why?
|
| Child Development Disorders, Pervasive | 3 | 2013 | 82 | 0.280 |
Why?
|
| Gene Transfer, Horizontal | 6 | 2020 | 43 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2020 | 370 | 0.280 |
Why?
|
| Behavior, Animal | 3 | 2020 | 491 | 0.270 |
Why?
|
| Species Specificity | 12 | 2022 | 550 | 0.270 |
Why?
|
| Molecular Diagnostic Techniques | 3 | 2021 | 150 | 0.270 |
Why?
|
| Kidney Neoplasms | 3 | 2016 | 431 | 0.270 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 2 | 2019 | 145 | 0.270 |
Why?
|
| DNA | 16 | 2022 | 1600 | 0.270 |
Why?
|
| Metabolome | 3 | 2019 | 294 | 0.270 |
Why?
|
| Linkage Disequilibrium | 9 | 2019 | 309 | 0.270 |
Why?
|
| Optic Atrophy | 3 | 2016 | 47 | 0.270 |
Why?
|
| Cilia | 2 | 2020 | 76 | 0.260 |
Why?
|
| Infant, Newborn | 18 | 2023 | 8182 | 0.260 |
Why?
|
| Immunity | 4 | 2021 | 191 | 0.260 |
Why?
|
| Case-Control Studies | 13 | 2023 | 3287 | 0.260 |
Why?
|
| Genetic Speciation | 4 | 2020 | 25 | 0.260 |
Why?
|
| Osteochondrodysplasias | 2 | 2019 | 68 | 0.260 |
Why?
|
| Neurodegenerative Diseases | 3 | 2018 | 252 | 0.260 |
Why?
|
| Consanguinity | 5 | 2018 | 104 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2006 | 93 | 0.250 |
Why?
|
| Malformations of Cortical Development | 3 | 2017 | 54 | 0.250 |
Why?
|
| Multifactorial Inheritance | 4 | 2021 | 139 | 0.250 |
Why?
|
| Simian Immunodeficiency Virus | 2 | 2018 | 92 | 0.250 |
Why?
|
| Lipid Metabolism | 3 | 2021 | 359 | 0.250 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2018 | 691 | 0.250 |
Why?
|
| Inheritance Patterns | 5 | 2018 | 124 | 0.250 |
Why?
|
| Conserved Sequence | 10 | 2020 | 293 | 0.250 |
Why?
|
| Bone Diseases, Developmental | 2 | 2017 | 58 | 0.250 |
Why?
|
| Atrial Fibrillation | 3 | 2020 | 661 | 0.250 |
Why?
|
| Viral Load | 2 | 2025 | 385 | 0.250 |
Why?
|
| Peripheral Nervous System Diseases | 3 | 2015 | 125 | 0.250 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2015 | 1019 | 0.250 |
Why?
|
| Syndrome | 9 | 2019 | 1118 | 0.250 |
Why?
|
| Genetics, Medical | 7 | 2020 | 117 | 0.240 |
Why?
|
| Phosphoproteins | 3 | 2017 | 404 | 0.240 |
Why?
|
| Genomic Structural Variation | 4 | 2024 | 86 | 0.240 |
Why?
|
| Heart Conduction System | 2 | 2018 | 147 | 0.240 |
Why?
|
| Diptera | 2 | 2015 | 22 | 0.240 |
Why?
|
| Point Mutation | 3 | 2016 | 348 | 0.240 |
Why?
|
| Multiple Endocrine Neoplasia | 1 | 2025 | 22 | 0.240 |
Why?
|
| Dishevelled Proteins | 3 | 2020 | 43 | 0.240 |
Why?
|
| Retinitis Pigmentosa | 3 | 2015 | 84 | 0.240 |
Why?
|
| Wasps | 2 | 2018 | 10 | 0.240 |
Why?
|
| Receptors, Odorant | 4 | 2020 | 36 | 0.230 |
Why?
|
| Bees | 2 | 2015 | 25 | 0.230 |
Why?
|
| B-Lymphocytes | 2 | 2020 | 530 | 0.230 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2023 | 467 | 0.230 |
Why?
|
| Centromere | 6 | 2017 | 107 | 0.230 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 598 | 0.230 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2021 | 1272 | 0.230 |
Why?
|
| Trans-Activators | 3 | 2025 | 808 | 0.230 |
Why?
|
| Health | 3 | 2020 | 37 | 0.230 |
Why?
|
| Chromosomes | 4 | 2015 | 199 | 0.230 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2020 | 475 | 0.220 |
Why?
|
| DNA Replication | 6 | 2019 | 351 | 0.220 |
Why?
|
| Receptors, Cell Surface | 2 | 2018 | 471 | 0.220 |
Why?
|
| Severe Combined Immunodeficiency | 2 | 2014 | 105 | 0.220 |
Why?
|
| Signal Transduction | 15 | 2023 | 4542 | 0.220 |
Why?
|
| Minichromosome Maintenance Proteins | 2 | 2020 | 9 | 0.220 |
Why?
|
| Oncogenes | 3 | 2021 | 169 | 0.220 |
Why?
|
| Polycythemia Vera | 2 | 2014 | 38 | 0.220 |
Why?
|
| Gene Deletion | 5 | 2016 | 795 | 0.220 |
Why?
|
| Muscle Weakness | 2 | 2016 | 84 | 0.220 |
Why?
|
| Aged | 24 | 2020 | 19691 | 0.220 |
Why?
|
| Algorithms | 7 | 2022 | 1616 | 0.220 |
Why?
|
| Neoplasms | 6 | 2021 | 2788 | 0.220 |
Why?
|
| Dictyostelium | 3 | 2015 | 114 | 0.210 |
Why?
|
| ADAM Proteins | 2 | 2014 | 78 | 0.210 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2021 | 1135 | 0.210 |
Why?
|
| Bone Marrow Transplantation | 2 | 2024 | 578 | 0.210 |
Why?
|
| Adenocarcinoma | 2 | 2024 | 1000 | 0.210 |
Why?
|
| Microbiota | 2 | 2019 | 390 | 0.210 |
Why?
|
| Laboratories | 1 | 2024 | 82 | 0.210 |
Why?
|
| Cloning, Molecular | 12 | 2009 | 892 | 0.210 |
Why?
|
| 46, XX Disorders of Sex Development | 1 | 2023 | 22 | 0.210 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2025 | 211 | 0.210 |
Why?
|
| Gene Silencing | 2 | 2014 | 238 | 0.210 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2016 | 237 | 0.210 |
Why?
|
| Circulating Tumor DNA | 1 | 2023 | 33 | 0.210 |
Why?
|
| Siblings | 4 | 2018 | 196 | 0.210 |
Why?
|
| Blood Glucose | 3 | 2021 | 1142 | 0.210 |
Why?
|
| Transposition of Great Vessels | 1 | 2024 | 131 | 0.200 |
Why?
|
| RNA, Messenger | 12 | 2018 | 2825 | 0.200 |
Why?
|
| Wnt Proteins | 3 | 2018 | 195 | 0.200 |
Why?
|
| Skin Neoplasms | 3 | 2015 | 804 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 5 | 2021 | 1113 | 0.200 |
Why?
|
| Yaws | 2 | 2012 | 5 | 0.200 |
Why?
|
| Databases, Nucleic Acid | 3 | 2017 | 70 | 0.200 |
Why?
|
| Transcription, Genetic | 7 | 2018 | 1704 | 0.200 |
Why?
|
| Factor VIII | 1 | 2022 | 45 | 0.200 |
Why?
|
| Neoplasms, Second Primary | 1 | 2024 | 154 | 0.200 |
Why?
|
| Treponema pallidum | 2 | 2012 | 49 | 0.200 |
Why?
|
| Mesocricetus | 1 | 2022 | 72 | 0.200 |
Why?
|
| Golgi Apparatus | 3 | 2021 | 93 | 0.200 |
Why?
|
| Hemostatics | 1 | 2022 | 58 | 0.190 |
Why?
|
| Reproducibility of Results | 11 | 2021 | 2880 | 0.190 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2022 | 32 | 0.190 |
Why?
|
| Sertoli-Leydig Cell Tumor | 1 | 2022 | 16 | 0.190 |
Why?
|
| Proteogenomics | 1 | 2022 | 67 | 0.190 |
Why?
|
| Cryptosporidium | 1 | 2022 | 31 | 0.190 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2022 | 61 | 0.190 |
Why?
|
| Cryptosporidium parvum | 1 | 2022 | 27 | 0.190 |
Why?
|
| Cryptosporidiosis | 1 | 2022 | 41 | 0.190 |
Why?
|
| Physical Chromosome Mapping | 3 | 2015 | 56 | 0.190 |
Why?
|
| Gene Expression | 8 | 2016 | 1570 | 0.190 |
Why?
|
| DNA Primers | 4 | 2015 | 660 | 0.190 |
Why?
|
| Epigenesis, Genetic | 3 | 2021 | 675 | 0.190 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 2 | 2018 | 401 | 0.190 |
Why?
|
| Neptune | 1 | 2021 | 4 | 0.190 |
Why?
|
| Coat Protein Complex I | 1 | 2021 | 14 | 0.190 |
Why?
|
| Mitochondria | 2 | 2016 | 692 | 0.190 |
Why?
|
| Genes | 9 | 2009 | 445 | 0.190 |
Why?
|
| Insulin | 3 | 2016 | 1210 | 0.190 |
Why?
|
| Cell Line | 10 | 2022 | 2771 | 0.190 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2023 | 150 | 0.190 |
Why?
|
| Population Health | 1 | 2022 | 37 | 0.190 |
Why?
|
| Genetic Fitness | 2 | 2018 | 34 | 0.190 |
Why?
|
| Syphilis | 2 | 2012 | 96 | 0.190 |
Why?
|
| Pest Control, Biological | 2 | 2018 | 14 | 0.190 |
Why?
|
| Amino Acid Substitution | 6 | 2020 | 393 | 0.180 |
Why?
|
| Ribonuclease III | 1 | 2022 | 89 | 0.180 |
Why?
|
| Immunologic Memory | 2 | 2020 | 185 | 0.180 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2021 | 44 | 0.180 |
Why?
|
| Genome, Viral | 3 | 2021 | 167 | 0.180 |
Why?
|
| Transplants | 1 | 2021 | 35 | 0.180 |
Why?
|
| Macaca | 3 | 2018 | 61 | 0.180 |
Why?
|
| Turkey | 5 | 2021 | 59 | 0.180 |
Why?
|
| RNA-Binding Proteins | 3 | 2022 | 577 | 0.180 |
Why?
|
| Life History Traits | 1 | 2020 | 5 | 0.180 |
Why?
|
| Thysanoptera | 1 | 2020 | 5 | 0.180 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2018 | 339 | 0.180 |
Why?
|
| Human Migration | 1 | 2020 | 11 | 0.180 |
Why?
|
| Wnt Signaling Pathway | 3 | 2020 | 196 | 0.180 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2020 | 17 | 0.180 |
Why?
|
| Coronary Disease | 2 | 2015 | 673 | 0.180 |
Why?
|
| Human Genome Project | 5 | 2015 | 55 | 0.180 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2021 | 34 | 0.180 |
Why?
|
| Pathology, Molecular | 2 | 2018 | 58 | 0.180 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2016 | 211 | 0.180 |
Why?
|
| Vesicular Transport Proteins | 2 | 2019 | 120 | 0.180 |
Why?
|
| Mutation Accumulation | 1 | 2020 | 1 | 0.180 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 18 | 0.180 |
Why?
|
| Venous Thrombosis | 2 | 2013 | 182 | 0.180 |
Why?
|
| Hymenoptera | 1 | 2020 | 7 | 0.180 |
Why?
|
| Myxomycetes | 1 | 2020 | 4 | 0.170 |
Why?
|
| Polyketide Synthases | 1 | 2020 | 5 | 0.170 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2020 | 28 | 0.170 |
Why?
|
| Cercocebus atys | 2 | 2018 | 11 | 0.170 |
Why?
|
| Osteoporosis | 1 | 2021 | 116 | 0.170 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2020 | 28 | 0.170 |
Why?
|
| Paternal Age | 1 | 2020 | 13 | 0.170 |
Why?
|
| Genomic Imprinting | 2 | 2019 | 123 | 0.170 |
Why?
|
| Social Skills | 1 | 2020 | 15 | 0.170 |
Why?
|
| Protozoan Proteins | 2 | 2020 | 108 | 0.170 |
Why?
|
| Alternative Splicing | 5 | 2017 | 350 | 0.170 |
Why?
|
| Molecular Chaperones | 2 | 2018 | 168 | 0.170 |
Why?
|
| Sequence Deletion | 7 | 2018 | 528 | 0.170 |
Why?
|
| Insecticides | 3 | 2016 | 52 | 0.170 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2018 | 154 | 0.170 |
Why?
|
| Leukemia | 1 | 2023 | 370 | 0.170 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2014 | 662 | 0.170 |
Why?
|
| Mediator Complex | 2 | 2020 | 52 | 0.170 |
Why?
|
| Healthy Volunteers | 2 | 2017 | 134 | 0.170 |
Why?
|
| Cell Line, Tumor | 8 | 2019 | 3341 | 0.170 |
Why?
|
| Ependymoma | 1 | 2021 | 134 | 0.170 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2019 | 31 | 0.170 |
Why?
|
| C-Reactive Protein | 2 | 2019 | 427 | 0.170 |
Why?
|
| Arabs | 2 | 2016 | 29 | 0.160 |
Why?
|
| Genes, X-Linked | 3 | 2016 | 59 | 0.160 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 13 | 2008 | 369 | 0.160 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 361 | 0.160 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 234 | 0.160 |
Why?
|
| CpG Islands | 7 | 2015 | 323 | 0.160 |
Why?
|
| Carcinoma | 2 | 2013 | 285 | 0.160 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2019 | 32 | 0.160 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 152 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 12 | 4 | 2006 | 95 | 0.160 |
Why?
|
| Blood Pressure | 2 | 2015 | 1348 | 0.160 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2022 | 203 | 0.160 |
Why?
|
| Papio | 2 | 2019 | 60 | 0.160 |
Why?
|
| DNA Repair | 6 | 2020 | 587 | 0.160 |
Why?
|
| X Chromosome Inactivation | 2 | 2016 | 63 | 0.160 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2020 | 73 | 0.160 |
Why?
|
| Sodium-Glucose Transport Proteins | 1 | 2019 | 3 | 0.160 |
Why?
|
| Models, Molecular | 8 | 2019 | 1075 | 0.160 |
Why?
|
| Bone and Bones | 1 | 2021 | 266 | 0.160 |
Why?
|
| Hemiptera | 1 | 2019 | 10 | 0.160 |
Why?
|
| Tubulin | 2 | 2017 | 104 | 0.160 |
Why?
|
| Deoxyglucose | 1 | 2019 | 34 | 0.160 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2019 | 30 | 0.160 |
Why?
|
| DNA Damage | 2 | 2020 | 515 | 0.160 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2019 | 84 | 0.160 |
Why?
|
| Hypertension | 3 | 2016 | 1314 | 0.160 |
Why?
|
| Primate Diseases | 1 | 2018 | 4 | 0.160 |
Why?
|
| Walker-Warburg Syndrome | 1 | 2018 | 5 | 0.160 |
Why?
|
| Cerebellar Ataxia | 1 | 2019 | 66 | 0.160 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2019 | 42 | 0.160 |
Why?
|
| Organ Transplantation | 1 | 2021 | 165 | 0.160 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2019 | 96 | 0.160 |
Why?
|
| RNA Helicases | 1 | 2019 | 63 | 0.160 |
Why?
|
| Adenosine Triphosphatases | 2 | 2017 | 208 | 0.160 |
Why?
|
| DNA, Neoplasm | 2 | 2018 | 303 | 0.160 |
Why?
|
| Population Groups | 3 | 2017 | 30 | 0.160 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 58 | 0.160 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2018 | 235 | 0.160 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2021 | 197 | 0.150 |
Why?
|
| Boron Compounds | 1 | 1998 | 32 | 0.150 |
Why?
|
| Clinical Protocols | 1 | 2020 | 236 | 0.150 |
Why?
|
| Pyrazoles | 1 | 2021 | 307 | 0.150 |
Why?
|
| Gene Rearrangement | 8 | 2019 | 321 | 0.150 |
Why?
|
| Multiprotein Complexes | 2 | 2016 | 207 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2019 | 100 | 0.150 |
Why?
|
| Cell Cycle | 3 | 2019 | 615 | 0.150 |
Why?
|
| Herpesvirus 4, Human | 2 | 2021 | 673 | 0.150 |
Why?
|
| Lung | 4 | 2025 | 1491 | 0.150 |
Why?
|
| Chromosome Breakage | 3 | 2008 | 168 | 0.150 |
Why?
|
| DNA Transposable Elements | 8 | 2020 | 177 | 0.150 |
Why?
|
| Recombination, Genetic | 8 | 2019 | 449 | 0.150 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 171 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2015 | 1899 | 0.150 |
Why?
|
| Disease | 3 | 2014 | 129 | 0.150 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2018 | 113 | 0.150 |
Why?
|
| NAV1.8 Voltage-Gated Sodium Channel | 1 | 2018 | 5 | 0.150 |
Why?
|
| Microarray Analysis | 1 | 2019 | 230 | 0.150 |
Why?
|
| Amphipoda | 1 | 2018 | 4 | 0.150 |
Why?
|
| Receptors, Interleukin | 1 | 2018 | 33 | 0.150 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2020 | 292 | 0.150 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2022 | 341 | 0.150 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2018 | 18 | 0.150 |
Why?
|
| Pyrimidines | 1 | 2021 | 372 | 0.150 |
Why?
|
| RNA Interference | 3 | 2018 | 504 | 0.150 |
Why?
|
| Blattellidae | 1 | 2018 | 3 | 0.150 |
Why?
|
| Prognosis | 8 | 2021 | 4607 | 0.150 |
Why?
|
| Isoptera | 1 | 2018 | 4 | 0.150 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2018 | 29 | 0.150 |
Why?
|
| Cytochrome P-450 CYP2A6 | 1 | 2018 | 13 | 0.150 |
Why?
|
| Exonucleases | 2 | 2015 | 23 | 0.150 |
Why?
|
| Spleen | 1 | 2019 | 282 | 0.150 |
Why?
|
| Francisella | 1 | 2017 | 4 | 0.150 |
Why?
|
| Quantitative Trait, Heritable | 3 | 2014 | 106 | 0.150 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 4 | 2016 | 163 | 0.150 |
Why?
|
| Brain | 5 | 2021 | 3010 | 0.150 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2018 | 31 | 0.150 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 111 | 0.150 |
Why?
|
| Water Pollutants, Chemical | 1 | 2018 | 23 | 0.150 |
Why?
|
| Host Specificity | 1 | 2018 | 18 | 0.150 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2016 | 538 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 3 | 2015 | 374 | 0.150 |
Why?
|
| Tularemia | 1 | 2017 | 13 | 0.150 |
Why?
|
| Mycobiome | 1 | 2017 | 8 | 0.150 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 298 | 0.150 |
Why?
|
| Sequence Homology, Nucleic Acid | 11 | 2011 | 286 | 0.150 |
Why?
|
| Primary Myelofibrosis | 1 | 2018 | 51 | 0.150 |
Why?
|
| Ovarian Neoplasms | 1 | 2022 | 418 | 0.140 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2019 | 214 | 0.140 |
Why?
|
| Spiders | 1 | 2017 | 6 | 0.140 |
Why?
|
| Eye Proteins | 2 | 2021 | 219 | 0.140 |
Why?
|
| MAP Kinase Kinase 1 | 2 | 2014 | 39 | 0.140 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2017 | 6 | 0.140 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2020 | 229 | 0.140 |
Why?
|
| Fibromatosis, Gingival | 1 | 2017 | 4 | 0.140 |
Why?
|
| Ion Channel Gating | 1 | 2018 | 123 | 0.140 |
Why?
|
| Muscle Proteins | 2 | 2017 | 417 | 0.140 |
Why?
|
| Sheep | 1 | 2018 | 215 | 0.140 |
Why?
|
| Biodiversity | 2 | 2015 | 64 | 0.140 |
Why?
|
| Haploinsufficiency | 2 | 2021 | 257 | 0.140 |
Why?
|
| Synaptic Transmission | 1 | 2020 | 350 | 0.140 |
Why?
|
| Aged, 80 and over | 10 | 2020 | 6521 | 0.140 |
Why?
|
| MicroRNAs | 7 | 2016 | 842 | 0.140 |
Why?
|
| Blood Platelets | 2 | 2017 | 327 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2017 | 106 | 0.140 |
Why?
|
| Fetus | 2 | 2018 | 584 | 0.140 |
Why?
|
| Receptors, KIR | 1 | 2017 | 8 | 0.140 |
Why?
|
| Feeding Behavior | 3 | 2020 | 712 | 0.140 |
Why?
|
| Chromosomes, Human, Y | 3 | 2014 | 46 | 0.140 |
Why?
|
| Mobius Syndrome | 1 | 2017 | 8 | 0.140 |
Why?
|
| Introns | 7 | 2017 | 301 | 0.140 |
Why?
|
| Adaptation, Physiological | 2 | 2018 | 272 | 0.140 |
Why?
|
| Hemizygote | 1 | 2017 | 13 | 0.140 |
Why?
|
| Fluorescent Dyes | 1 | 1998 | 262 | 0.140 |
Why?
|
| Fungi | 1 | 2017 | 69 | 0.140 |
Why?
|
| RNA, Transfer | 3 | 2014 | 72 | 0.140 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2017 | 26 | 0.140 |
Why?
|
| Population Density | 5 | 2018 | 34 | 0.140 |
Why?
|
| Longevity | 1 | 2018 | 140 | 0.140 |
Why?
|
| Macaca fascicularis | 1 | 2017 | 87 | 0.140 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2017 | 20 | 0.140 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2017 | 41 | 0.140 |
Why?
|
| Amino Acids | 2 | 2016 | 663 | 0.140 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2016 | 13 | 0.140 |
Why?
|
| Forkhead Transcription Factors | 2 | 2016 | 366 | 0.140 |
Why?
|
| Liddle Syndrome | 1 | 2016 | 4 | 0.140 |
Why?
|
| Epithelial Sodium Channels | 1 | 2016 | 15 | 0.140 |
Why?
|
| Cattle | 4 | 2020 | 566 | 0.140 |
Why?
|
| Coleoptera | 1 | 2016 | 13 | 0.140 |
Why?
|
| Ceratitis capitata | 1 | 2016 | 4 | 0.140 |
Why?
|
| Small Molecule Libraries | 1 | 2018 | 124 | 0.140 |
Why?
|
| Genetic Carrier Screening | 1 | 2017 | 68 | 0.140 |
Why?
|
| Interferon Regulatory Factors | 1 | 2016 | 38 | 0.140 |
Why?
|
| Mice, Knockout | 7 | 2020 | 3753 | 0.130 |
Why?
|
| Manduca | 1 | 2016 | 5 | 0.130 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2017 | 44 | 0.130 |
Why?
|
| Platelet Aggregation | 1 | 2017 | 121 | 0.130 |
Why?
|
| Mutagenesis | 3 | 2015 | 347 | 0.130 |
Why?
|
| Situs Inversus | 1 | 2016 | 25 | 0.130 |
Why?
|
| Virus Replication | 3 | 2022 | 611 | 0.130 |
Why?
|
| Sudden Infant Death | 1 | 2016 | 33 | 0.130 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 98 | 0.130 |
Why?
|
| Patient Selection | 1 | 2020 | 693 | 0.130 |
Why?
|
| NF-kappa B | 1 | 2019 | 457 | 0.130 |
Why?
|
| Nicotine | 1 | 2018 | 143 | 0.130 |
Why?
|
| Bardet-Biedl Syndrome | 2 | 2014 | 38 | 0.130 |
Why?
|
| GTPase-Activating Proteins | 1 | 2016 | 85 | 0.130 |
Why?
|
| Cytomegalovirus | 1 | 2018 | 270 | 0.130 |
Why?
|
| Feeding and Eating Disorders | 1 | 2017 | 70 | 0.130 |
Why?
|
| Anxiety | 2 | 2013 | 967 | 0.130 |
Why?
|
| Gene Flow | 3 | 2020 | 13 | 0.130 |
Why?
|
| Psychomotor Disorders | 1 | 2016 | 28 | 0.130 |
Why?
|
| Ectoparasitic Infestations | 1 | 2016 | 4 | 0.130 |
Why?
|
| Bedbugs | 1 | 2016 | 6 | 0.130 |
Why?
|
| Receptors, Notch | 2 | 2015 | 203 | 0.130 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2019 | 205 | 0.130 |
Why?
|
| Death, Sudden | 1 | 2016 | 45 | 0.130 |
Why?
|
| Pan troglodytes | 5 | 2012 | 71 | 0.130 |
Why?
|
| Sirolimus | 1 | 2018 | 223 | 0.130 |
Why?
|
| Epilepsy | 2 | 2016 | 873 | 0.130 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2016 | 45 | 0.130 |
Why?
|
| Smell | 2 | 2019 | 120 | 0.130 |
Why?
|
| T-Lymphocytes | 2 | 2015 | 1708 | 0.130 |
Why?
|
| Chordata, Nonvertebrate | 1 | 2015 | 5 | 0.130 |
Why?
|
| Geminin | 1 | 2015 | 7 | 0.130 |
Why?
|
| Cell Proliferation | 3 | 2020 | 2305 | 0.130 |
Why?
|
| Tenascin | 1 | 2016 | 31 | 0.130 |
Why?
|
| Duodenal Neoplasms | 1 | 2016 | 21 | 0.130 |
Why?
|
| Polyhydramnios | 1 | 2016 | 56 | 0.130 |
Why?
|
| Waardenburg Syndrome | 1 | 2015 | 10 | 0.130 |
Why?
|
| Sezary Syndrome | 1 | 2015 | 12 | 0.130 |
Why?
|
| Stem Cell Factor | 1 | 2015 | 13 | 0.130 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2015 | 7 | 0.130 |
Why?
|
| Transposases | 1 | 2016 | 40 | 0.130 |
Why?
|
| Functional Laterality | 1 | 2016 | 182 | 0.130 |
Why?
|
| Patella | 1 | 2015 | 25 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 4 | 2021 | 510 | 0.130 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2014 | 170 | 0.130 |
Why?
|
| Cardiology | 1 | 2021 | 502 | 0.130 |
Why?
|
| Janus Kinase 2 | 2 | 2014 | 134 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2015 | 28 | 0.130 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2011 | 204 | 0.130 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2016 | 81 | 0.130 |
Why?
|
| Cytomegalovirus Infections | 1 | 2018 | 218 | 0.130 |
Why?
|
| Brain Edema | 1 | 2016 | 69 | 0.130 |
Why?
|
| Genetic Load | 1 | 2015 | 5 | 0.130 |
Why?
|
| Congenital Microtia | 1 | 2015 | 16 | 0.130 |
Why?
|
| Rhabdomyolysis | 1 | 2016 | 37 | 0.130 |
Why?
|
| Klippel-Feil Syndrome | 1 | 2015 | 8 | 0.120 |
Why?
|
| Lymph Nodes | 1 | 2017 | 380 | 0.120 |
Why?
|
| Chromosome Deletion | 4 | 2014 | 647 | 0.120 |
Why?
|
| Loss of Heterozygosity | 2 | 2013 | 125 | 0.120 |
Why?
|
| Hylobates | 2 | 2014 | 10 | 0.120 |
Why?
|
| NADP Transhydrogenase, AB-Specific | 1 | 2015 | 4 | 0.120 |
Why?
|
| Cholesterol, HDL | 2 | 2017 | 357 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2016 | 59 | 0.120 |
Why?
|
| Severity of Illness Index | 6 | 2022 | 2903 | 0.120 |
Why?
|
| Polyneuropathies | 1 | 2015 | 29 | 0.120 |
Why?
|
| Hypogonadism | 2 | 2019 | 284 | 0.120 |
Why?
|
| United States | 11 | 2022 | 10886 | 0.120 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2015 | 83 | 0.120 |
Why?
|
| Atrophy | 1 | 2016 | 236 | 0.120 |
Why?
|
| Chloride Channels | 1 | 2015 | 63 | 0.120 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2016 | 58 | 0.120 |
Why?
|
| Myelin Proteins | 1 | 2015 | 76 | 0.120 |
Why?
|
| Plant Tumors | 1 | 2015 | 4 | 0.120 |
Why?
|
| DNA, Intergenic | 1 | 2015 | 17 | 0.120 |
Why?
|
| Epistasis, Genetic | 2 | 2012 | 93 | 0.120 |
Why?
|
| Homeodomain Proteins | 2 | 2020 | 546 | 0.120 |
Why?
|
| Larva | 4 | 2016 | 246 | 0.120 |
Why?
|
| Histidine Ammonia-Lyase | 1 | 2015 | 4 | 0.120 |
Why?
|
| Fractures, Bone | 1 | 2017 | 187 | 0.120 |
Why?
|
| Cell Differentiation | 3 | 2020 | 1929 | 0.120 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 113 | 0.120 |
Why?
|
| Carcinoma, Papillary | 1 | 2015 | 77 | 0.120 |
Why?
|
| Triticum | 1 | 2015 | 34 | 0.120 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2015 | 43 | 0.120 |
Why?
|
| Liver Neoplasms | 2 | 2016 | 1319 | 0.120 |
Why?
|
| Homocystinuria | 1 | 2015 | 21 | 0.120 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2014 | 22 | 0.120 |
Why?
|
| Clonal Evolution | 1 | 2015 | 41 | 0.120 |
Why?
|
| Autism Spectrum Disorder | 1 | 2020 | 393 | 0.120 |
Why?
|
| Chickenpox | 1 | 2014 | 20 | 0.120 |
Why?
|
| Hypopituitarism | 1 | 2015 | 17 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2015 | 724 | 0.120 |
Why?
|
| Rubella | 1 | 2014 | 21 | 0.120 |
Why?
|
| Histidine | 1 | 2015 | 72 | 0.120 |
Why?
|
| Parkinsonian Disorders | 1 | 2016 | 75 | 0.120 |
Why?
|
| De Lange Syndrome | 1 | 2015 | 44 | 0.120 |
Why?
|
| Cardiomyopathies | 2 | 2016 | 489 | 0.120 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2018 | 292 | 0.120 |
Why?
|
| Fetal Hemoglobin | 1 | 2014 | 28 | 0.120 |
Why?
|
| Oncogene Fusion | 1 | 2014 | 22 | 0.120 |
Why?
|
| Cyclin B | 1 | 2014 | 22 | 0.120 |
Why?
|
| Troponin T | 1 | 2017 | 282 | 0.120 |
Why?
|
| Karyotype | 1 | 2014 | 28 | 0.120 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2015 | 40 | 0.120 |
Why?
|
| Sequence Analysis | 1 | 2014 | 54 | 0.120 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2015 | 49 | 0.120 |
Why?
|
| Epidermodysplasia Verruciformis | 1 | 2014 | 6 | 0.120 |
Why?
|
| Leprosy, Tuberculoid | 1 | 2014 | 7 | 0.120 |
Why?
|
| Cluster Analysis | 4 | 2018 | 400 | 0.120 |
Why?
|
| Lymphopenia | 1 | 2014 | 36 | 0.120 |
Why?
|
| Pituitary Gland | 1 | 2015 | 84 | 0.120 |
Why?
|
| Cholesterol, LDL | 2 | 2017 | 568 | 0.120 |
Why?
|
| DNA Polymerase II | 1 | 2014 | 19 | 0.120 |
Why?
|
| Molluscum Contagiosum | 1 | 2014 | 11 | 0.120 |
Why?
|
| Receptors, Lipoprotein | 1 | 2014 | 11 | 0.120 |
Why?
|
| Phosphoglucomutase | 1 | 2014 | 7 | 0.120 |
Why?
|
| Fibrillar Collagens | 1 | 2014 | 15 | 0.120 |
Why?
|
| Arthritis | 1 | 2015 | 81 | 0.120 |
Why?
|
| Rumen | 1 | 2014 | 12 | 0.120 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2014 | 16 | 0.120 |
Why?
|
| Sensitivity and Specificity | 5 | 2021 | 2044 | 0.120 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2014 | 9 | 0.120 |
Why?
|
| Sheep, Domestic | 1 | 2014 | 17 | 0.120 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 334 | 0.120 |
Why?
|
| Hematopoiesis | 1 | 2016 | 220 | 0.120 |
Why?
|
| Datasets as Topic | 3 | 2020 | 88 | 0.120 |
Why?
|
| Telomere-Binding Proteins | 1 | 2014 | 43 | 0.120 |
Why?
|
| Cytokines | 1 | 2020 | 1291 | 0.120 |
Why?
|
| Founder Effect | 1 | 2014 | 31 | 0.110 |
Why?
|
| Internet | 2 | 2014 | 383 | 0.110 |
Why?
|
| Lipomatosis | 1 | 2014 | 16 | 0.110 |
Why?
|
| Scoliosis | 1 | 2016 | 135 | 0.110 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 1604 | 0.110 |
Why?
|
| Bone Density | 1 | 2016 | 320 | 0.110 |
Why?
|
| Demography | 2 | 2013 | 240 | 0.110 |
Why?
|
| Mucous Membrane | 1 | 2014 | 88 | 0.110 |
Why?
|
| Noonan Syndrome | 1 | 2014 | 30 | 0.110 |
Why?
|
| Alopecia | 1 | 2014 | 36 | 0.110 |
Why?
|
| Risk Factors | 9 | 2022 | 10272 | 0.110 |
Why?
|
| Phosphotransferases | 1 | 2014 | 41 | 0.110 |
Why?
|
| Population Growth | 1 | 2013 | 6 | 0.110 |
Why?
|
| Anophthalmos | 1 | 2014 | 24 | 0.110 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2014 | 28 | 0.110 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2014 | 78 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2014 | 86 | 0.110 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 367 | 0.110 |
Why?
|
| Hydroxyurea | 1 | 2014 | 82 | 0.110 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2014 | 38 | 0.110 |
Why?
|
| Spasms, Infantile | 1 | 2016 | 171 | 0.110 |
Why?
|
| Disease Progression | 5 | 2020 | 2055 | 0.110 |
Why?
|
| Population Dynamics | 2 | 2011 | 32 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2016 | 339 | 0.110 |
Why?
|
| Granuloma | 1 | 2014 | 68 | 0.110 |
Why?
|
| Vocal Cord Paralysis | 1 | 2015 | 68 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2014 | 119 | 0.110 |
Why?
|
| Introduced Species | 3 | 2020 | 22 | 0.110 |
Why?
|
| Bone Marrow Diseases | 1 | 2014 | 41 | 0.110 |
Why?
|
| Refsum Disease | 1 | 2013 | 4 | 0.110 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2014 | 34 | 0.110 |
Why?
|
| COUP Transcription Factor I | 1 | 2014 | 91 | 0.110 |
Why?
|
| Cells, Cultured | 6 | 2019 | 3061 | 0.110 |
Why?
|
| Virus Diseases | 1 | 2016 | 279 | 0.110 |
Why?
|
| Granulocytes | 1 | 2014 | 66 | 0.110 |
Why?
|
| RNA, Untranslated | 6 | 2014 | 112 | 0.110 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 2013 | 36 | 0.110 |
Why?
|
| Autistic Disorder | 2 | 2020 | 349 | 0.110 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 127 | 0.110 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2014 | 45 | 0.110 |
Why?
|
| Skin | 2 | 2014 | 512 | 0.110 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 480 | 0.110 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2013 | 42 | 0.110 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 92 | 0.110 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2014 | 90 | 0.110 |
Why?
|
| Uniparental Disomy | 1 | 2014 | 49 | 0.110 |
Why?
|
| Axons | 2 | 2016 | 394 | 0.110 |
Why?
|
| Metagenome | 2 | 2015 | 149 | 0.110 |
Why?
|
| Autophagy | 1 | 2016 | 395 | 0.110 |
Why?
|
| Fibroblasts | 4 | 2021 | 891 | 0.110 |
Why?
|
| Cerebral Palsy | 1 | 2015 | 80 | 0.110 |
Why?
|
| Central Nervous System Diseases | 1 | 2014 | 105 | 0.110 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2015 | 148 | 0.110 |
Why?
|
| Hand Deformities, Congenital | 1 | 2014 | 89 | 0.110 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 1664 | 0.110 |
Why?
|
| Base Composition | 6 | 2014 | 71 | 0.110 |
Why?
|
| Connexins | 1 | 2013 | 59 | 0.110 |
Why?
|
| Papillomavirus Infections | 2 | 2014 | 288 | 0.110 |
Why?
|
| Hypertriglyceridemia | 1 | 2014 | 102 | 0.110 |
Why?
|
| Macular Degeneration | 1 | 2015 | 114 | 0.100 |
Why?
|
| Marfan Syndrome | 1 | 2015 | 139 | 0.100 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2014 | 74 | 0.100 |
Why?
|
| Gene Expression Regulation, Bacterial | 3 | 2009 | 158 | 0.100 |
Why?
|
| Caenorhabditis elegans | 3 | 2023 | 225 | 0.100 |
Why?
|
| RNA Editing | 2 | 2014 | 34 | 0.100 |
Why?
|
| Neck | 1 | 2014 | 137 | 0.100 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2014 | 129 | 0.100 |
Why?
|
| Epilepsy, Generalized | 1 | 2013 | 64 | 0.100 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 3 | 2017 | 67 | 0.100 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2012 | 20 | 0.100 |
Why?
|
| Rett Syndrome | 1 | 2016 | 291 | 0.100 |
Why?
|
| Chromosome Breakpoints | 3 | 2019 | 80 | 0.100 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 389 | 0.100 |
Why?
|
| Genes, Bacterial | 5 | 2017 | 209 | 0.100 |
Why?
|
| Brain Diseases | 1 | 2015 | 301 | 0.100 |
Why?
|
| HEK293 Cells | 4 | 2017 | 753 | 0.100 |
Why?
|
| Face | 1 | 2014 | 180 | 0.100 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2018 | 963 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2015 | 355 | 0.100 |
Why?
|
| Fatal Outcome | 3 | 2020 | 356 | 0.100 |
Why?
|
| Language Development Disorders | 1 | 2014 | 174 | 0.100 |
Why?
|
| Urinary Bladder | 1 | 2014 | 245 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 251 | 0.100 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2012 | 21 | 0.100 |
Why?
|
| Ampicillin | 1 | 2012 | 58 | 0.100 |
Why?
|
| Colitis | 1 | 2014 | 154 | 0.100 |
Why?
|
| Contig Mapping | 4 | 2006 | 55 | 0.100 |
Why?
|
| Enterococcus faecium | 1 | 2012 | 17 | 0.100 |
Why?
|
| Colorectal Neoplasms | 2 | 2022 | 566 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 382 | 0.100 |
Why?
|
| Mouth Neoplasms | 1 | 2013 | 84 | 0.100 |
Why?
|
| Sarcoma | 1 | 2014 | 194 | 0.100 |
Why?
|
| Biomedical Research | 2 | 2016 | 519 | 0.100 |
Why?
|
| Pongo pygmaeus | 2 | 2011 | 7 | 0.100 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2011 | 7 | 0.100 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2016 | 464 | 0.100 |
Why?
|
| Bipolar Disorder | 2 | 2020 | 352 | 0.100 |
Why?
|
| Body Mass Index | 2 | 2017 | 1568 | 0.100 |
Why?
|
| Pediatric Obesity | 1 | 2017 | 386 | 0.100 |
Why?
|
| Adhesins, Bacterial | 2 | 2009 | 75 | 0.100 |
Why?
|
| Macropodidae | 1 | 2011 | 8 | 0.100 |
Why?
|
| Protein Biosynthesis | 3 | 2014 | 665 | 0.100 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2011 | 16 | 0.100 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2011 | 48 | 0.100 |
Why?
|
| Facies | 3 | 2018 | 156 | 0.100 |
Why?
|
| Hemostasis | 1 | 2012 | 70 | 0.090 |
Why?
|
| Chromatin | 5 | 2016 | 556 | 0.090 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2011 | 8 | 0.090 |
Why?
|
| Myosins | 1 | 2011 | 46 | 0.090 |
Why?
|
| Endoplasmic Reticulum Stress | 3 | 2018 | 121 | 0.090 |
Why?
|
| Treponema | 1 | 2011 | 7 | 0.090 |
Why?
|
| Consensus Sequence | 1 | 2011 | 59 | 0.090 |
Why?
|
| Stomach Neoplasms | 1 | 2017 | 540 | 0.090 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2011 | 63 | 0.090 |
Why?
|
| Leber Congenital Amaurosis | 1 | 2011 | 30 | 0.090 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2014 | 225 | 0.090 |
Why?
|
| Germ Cells | 2 | 2024 | 195 | 0.090 |
Why?
|
| F-Box Proteins | 1 | 2011 | 34 | 0.090 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2013 | 171 | 0.090 |
Why?
|
| Colon | 1 | 2014 | 352 | 0.090 |
Why?
|
| Principal Component Analysis | 3 | 2019 | 142 | 0.090 |
Why?
|
| Chromosome Inversion | 3 | 2006 | 76 | 0.090 |
Why?
|
| Pongo abelii | 1 | 2011 | 3 | 0.090 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2011 | 78 | 0.090 |
Why?
|
| Receptor, Notch1 | 1 | 2011 | 64 | 0.090 |
Why?
|
| Ciliary Motility Disorders | 1 | 2011 | 12 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 1 | 2011 | 19 | 0.090 |
Why?
|
| Expressed Sequence Tags | 3 | 2006 | 78 | 0.090 |
Why?
|
| Reproduction | 3 | 2020 | 239 | 0.090 |
Why?
|
| Ischemia | 1 | 2014 | 357 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 792 | 0.090 |
Why?
|
| Drosophila Proteins | 1 | 2016 | 722 | 0.090 |
Why?
|
| Gardnerella vaginalis | 1 | 2010 | 5 | 0.090 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2012 | 153 | 0.090 |
Why?
|
| Vaginosis, Bacterial | 1 | 2010 | 18 | 0.090 |
Why?
|
| Anemia, Sickle Cell | 1 | 2014 | 339 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2016 | 1291 | 0.090 |
Why?
|
| Patient Care | 1 | 2011 | 99 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2016 | 658 | 0.090 |
Why?
|
| Biomarkers | 2 | 2016 | 3063 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 2 | 2023 | 324 | 0.090 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2013 | 252 | 0.090 |
Why?
|
| beta-Lactamases | 1 | 2012 | 192 | 0.090 |
Why?
|
| Base Pairing | 1 | 2010 | 43 | 0.090 |
Why?
|
| Seizures | 2 | 2014 | 879 | 0.090 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2011 | 77 | 0.090 |
Why?
|
| NIH 3T3 Cells | 2 | 2023 | 94 | 0.090 |
Why?
|
| Drosophila | 3 | 2016 | 781 | 0.080 |
Why?
|
| Microsatellite Repeats | 3 | 2019 | 219 | 0.080 |
Why?
|
| RNA Splicing | 3 | 2016 | 226 | 0.080 |
Why?
|
| Ion Channels | 1 | 2011 | 194 | 0.080 |
Why?
|
| Dystonic Disorders | 1 | 2011 | 85 | 0.080 |
Why?
|
| Gene Amplification | 6 | 2020 | 228 | 0.080 |
Why?
|
| Escherichia coli | 4 | 2012 | 986 | 0.080 |
Why?
|
| Crossing Over, Genetic | 3 | 2020 | 50 | 0.080 |
Why?
|
| Genotyping Techniques | 3 | 2016 | 103 | 0.080 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 338 | 0.080 |
Why?
|
| Fimbriae, Bacterial | 1 | 2009 | 42 | 0.080 |
Why?
|
| Heart | 1 | 2014 | 724 | 0.080 |
Why?
|
| Brucella abortus | 1 | 1989 | 4 | 0.080 |
Why?
|
| Streptococcus | 1 | 2009 | 61 | 0.080 |
Why?
|
| Proteomics | 2 | 2023 | 500 | 0.080 |
Why?
|
| Mannosidases | 1 | 2009 | 18 | 0.080 |
Why?
|
| Vaccination | 1 | 2014 | 952 | 0.080 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2009 | 37 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2016 | 938 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2023 | 246 | 0.080 |
Why?
|
| Embryonic Development | 3 | 2019 | 210 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2023 | 762 | 0.080 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 5 | 0.080 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 11 | 0.080 |
Why?
|
| Pulmonary Alveolar Proteinosis | 1 | 2008 | 6 | 0.080 |
Why?
|
| LIM Domain Proteins | 2 | 2020 | 59 | 0.080 |
Why?
|
| Interspersed Repetitive Sequences | 3 | 2015 | 27 | 0.080 |
Why?
|
| Moyamoya Disease | 1 | 2009 | 38 | 0.080 |
Why?
|
| ras Proteins | 3 | 2014 | 137 | 0.080 |
Why?
|
| Connectin | 2 | 2019 | 27 | 0.080 |
Why?
|
| Parents | 3 | 2023 | 1029 | 0.080 |
Why?
|
| Liver Failure | 1 | 2009 | 89 | 0.080 |
Why?
|
| MutL Protein Homolog 1 | 2 | 2022 | 54 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 3726 | 0.080 |
Why?
|
| Rats | 6 | 2016 | 3689 | 0.080 |
Why?
|
| Tribolium | 1 | 2008 | 7 | 0.080 |
Why?
|
| Endoribonucleases | 2 | 2022 | 82 | 0.080 |
Why?
|
| Longitudinal Studies | 2 | 2025 | 1327 | 0.080 |
Why?
|
| Genes, Neoplasm | 1 | 2008 | 80 | 0.080 |
Why?
|
| DNA, Mitochondrial | 4 | 2014 | 211 | 0.080 |
Why?
|
| Testis | 3 | 2020 | 411 | 0.070 |
Why?
|
| Embryo, Nonmammalian | 2 | 2021 | 144 | 0.070 |
Why?
|
| Enterococcus faecalis | 1 | 2008 | 44 | 0.070 |
Why?
|
| Retinal Degeneration | 1 | 2009 | 93 | 0.070 |
Why?
|
| Diabetes Mellitus | 2 | 2013 | 872 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2021 | 1001 | 0.070 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2008 | 364 | 0.070 |
Why?
|
| Embryo, Mammalian | 3 | 2016 | 456 | 0.070 |
Why?
|
| Sequence Homology | 3 | 2015 | 63 | 0.070 |
Why?
|
| Genetic Therapy | 1 | 2012 | 683 | 0.070 |
Why?
|
| Age Factors | 3 | 2020 | 2817 | 0.070 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2019 | 133 | 0.070 |
Why?
|
| Genome Size | 2 | 2020 | 15 | 0.070 |
Why?
|
| RNA, Small Interfering | 2 | 2021 | 670 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2011 | 2509 | 0.070 |
Why?
|
| Bacillus | 1 | 2007 | 35 | 0.070 |
Why?
|
| Endoplasmic Reticulum | 2 | 2021 | 218 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 9 | 2007 | 1587 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 2012 | 764 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 3 | 2014 | 316 | 0.070 |
Why?
|
| Prospective Studies | 4 | 2024 | 6137 | 0.070 |
Why?
|
| Chromosome Duplication | 2 | 2019 | 147 | 0.070 |
Why?
|
| Immunophenotyping | 2 | 2018 | 330 | 0.070 |
Why?
|
| Biopsy | 2 | 2021 | 1239 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2007 | 113 | 0.070 |
Why?
|
| Organ Specificity | 2 | 2020 | 427 | 0.070 |
Why?
|
| Homeostasis | 1 | 2011 | 692 | 0.070 |
Why?
|
| Strongylocentrotus purpuratus | 1 | 2006 | 5 | 0.070 |
Why?
|
| von Willebrand Factor | 2 | 2022 | 196 | 0.070 |
Why?
|
| Mannheimia haemolytica | 1 | 2006 | 2 | 0.070 |
Why?
|
| Transformation, Bacterial | 1 | 2006 | 11 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 1 | 2011 | 498 | 0.070 |
Why?
|
| Glucose | 1 | 2011 | 885 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 1022 | 0.070 |
Why?
|
| Chemoreceptor Cells | 2 | 2017 | 14 | 0.070 |
Why?
|
| Peptides | 3 | 2017 | 794 | 0.070 |
Why?
|
| Iduronate Sulfatase | 2 | 1997 | 20 | 0.070 |
Why?
|
| Platelet Count | 2 | 2017 | 136 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 3 | 2014 | 756 | 0.070 |
Why?
|
| Telomere | 4 | 2012 | 209 | 0.060 |
Why?
|
| Retrospective Studies | 7 | 2020 | 16299 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 2 | 2020 | 269 | 0.060 |
Why?
|
| Urate Oxidase | 3 | 1992 | 16 | 0.060 |
Why?
|
| Genome, Mitochondrial | 2 | 2017 | 31 | 0.060 |
Why?
|
| Chromosome Segregation | 2 | 2017 | 63 | 0.060 |
Why?
|
| Euchromatin | 2 | 2002 | 13 | 0.060 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2016 | 163 | 0.060 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2012 | 779 | 0.060 |
Why?
|
| Nucleotide Motifs | 2 | 2016 | 43 | 0.060 |
Why?
|
| South Africa | 2 | 2020 | 100 | 0.060 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2018 | 109 | 0.060 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2018 | 369 | 0.060 |
Why?
|
| Workflow | 2 | 2017 | 117 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2017 | 282 | 0.060 |
Why?
|
| Selenoproteins | 2 | 2015 | 13 | 0.060 |
Why?
|
| Mutant Proteins | 2 | 2018 | 112 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 2018 | 349 | 0.060 |
Why?
|
| India | 3 | 2011 | 219 | 0.060 |
Why?
|
| Binding Sites | 3 | 2019 | 1297 | 0.060 |
Why?
|
| Liver | 5 | 2021 | 1764 | 0.060 |
Why?
|
| Feces | 2 | 2019 | 717 | 0.060 |
Why?
|
| Animals, Genetically Modified | 2 | 2016 | 315 | 0.060 |
Why?
|
| Protein Transport | 2 | 2017 | 369 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2020 | 1624 | 0.060 |
Why?
|
| Melanoma | 1 | 2011 | 834 | 0.060 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2018 | 158 | 0.060 |
Why?
|
| Neural Conduction | 2 | 2015 | 93 | 0.060 |
Why?
|
| Rickettsia typhi | 1 | 2004 | 12 | 0.060 |
Why?
|
| Protein Stability | 2 | 2015 | 165 | 0.060 |
Why?
|
| Breeding | 2 | 2018 | 20 | 0.060 |
Why?
|
| Vision, Ocular | 2 | 2020 | 122 | 0.060 |
Why?
|
| Lymphocyte Activation | 2 | 2018 | 692 | 0.060 |
Why?
|
| Rats, Inbred BN | 1 | 2004 | 16 | 0.060 |
Why?
|
| Radiography | 2 | 2018 | 828 | 0.060 |
Why?
|
| Japan | 2 | 2014 | 133 | 0.060 |
Why?
|
| Body Patterning | 2 | 2019 | 124 | 0.060 |
Why?
|
| Genetic Complementation Test | 2 | 2015 | 87 | 0.060 |
Why?
|
| Insecta | 2 | 2017 | 57 | 0.060 |
Why?
|
| Pilot Projects | 3 | 2017 | 1402 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 2007 | 460 | 0.060 |
Why?
|
| Depression | 1 | 2012 | 1244 | 0.060 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2016 | 213 | 0.060 |
Why?
|
| Microsatellite Instability | 2 | 2014 | 36 | 0.060 |
Why?
|
| Telomerase | 2 | 2014 | 160 | 0.050 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2015 | 158 | 0.050 |
Why?
|
| Hominidae | 2 | 2014 | 27 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 5153 | 0.050 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2023 | 58 | 0.050 |
Why?
|
| Gene Order | 2 | 2014 | 79 | 0.050 |
Why?
|
| Gastrointestinal Tract | 2 | 2019 | 215 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2023 | 26 | 0.050 |
Why?
|
| Gestational Age | 2 | 2019 | 1161 | 0.050 |
Why?
|
| RNA, Ribosomal | 1 | 2003 | 63 | 0.050 |
Why?
|
| Heart Failure | 1 | 2016 | 2302 | 0.050 |
Why?
|
| X-ray Repair Cross Complementing Protein 1 | 1 | 2022 | 21 | 0.050 |
Why?
|
| Iran | 1 | 2023 | 59 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 1894 | 0.050 |
Why?
|
| Cosmids | 4 | 1995 | 48 | 0.050 |
Why?
|
| Arteries | 1 | 2024 | 219 | 0.050 |
Why?
|
| Qa-SNARE Proteins | 1 | 2022 | 21 | 0.050 |
Why?
|
| Factor VII | 1 | 2022 | 15 | 0.050 |
Why?
|
| Family Health | 2 | 2015 | 259 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 3 | 2014 | 1341 | 0.050 |
Why?
|
| Carboplatin | 1 | 2022 | 77 | 0.050 |
Why?
|
| Proteome | 4 | 2008 | 243 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 2007 | 558 | 0.050 |
Why?
|
| Host-Pathogen Interactions | 1 | 2025 | 254 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2022 | 42 | 0.050 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2022 | 40 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 768 | 0.050 |
Why?
|
| Immunity, Innate | 2 | 2020 | 372 | 0.050 |
Why?
|
| Loss of Function Mutation | 1 | 2023 | 145 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2014 | 833 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 92 | 0.050 |
Why?
|
| DNA Mismatch Repair | 1 | 2022 | 48 | 0.050 |
Why?
|
| Calcium Channels | 2 | 2014 | 159 | 0.050 |
Why?
|
| Muscles | 2 | 2016 | 289 | 0.050 |
Why?
|
| A549 Cells | 1 | 2022 | 43 | 0.050 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2022 | 43 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2022 | 153 | 0.050 |
Why?
|
| Rare Diseases | 1 | 2024 | 192 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2021 | 826 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 116 | 0.050 |
Why?
|
| Quality Control | 2 | 1998 | 119 | 0.050 |
Why?
|
| Receptor, trkB | 1 | 2021 | 20 | 0.050 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2022 | 72 | 0.050 |
Why?
|
| RNA | 5 | 2011 | 568 | 0.050 |
Why?
|
| Immune Evasion | 1 | 2021 | 35 | 0.050 |
Why?
|
| Pharmacogenomic Testing | 1 | 2021 | 37 | 0.050 |
Why?
|
| Transcription Initiation Site | 2 | 2014 | 32 | 0.050 |
Why?
|
| Bacteria | 2 | 2019 | 484 | 0.050 |
Why?
|
| Prevalence | 2 | 2021 | 2451 | 0.050 |
Why?
|
| Turner Syndrome | 2 | 2014 | 46 | 0.050 |
Why?
|
| Subcutaneous Tissue | 1 | 2021 | 15 | 0.050 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 78 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2023 | 701 | 0.050 |
Why?
|
| Age of Onset | 2 | 2015 | 582 | 0.050 |
Why?
|
| Collagen Type I | 1 | 2021 | 112 | 0.050 |
Why?
|
| Cercopithecidae | 1 | 2020 | 7 | 0.050 |
Why?
|
| Stroke | 1 | 2009 | 986 | 0.050 |
Why?
|
| Fossils | 1 | 2020 | 8 | 0.050 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 2 | 1991 | 35 | 0.050 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2009 | 670 | 0.050 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2020 | 4 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 4 | 2007 | 395 | 0.040 |
Why?
|
| Food Chain | 1 | 2020 | 10 | 0.040 |
Why?
|
| Crops, Agricultural | 1 | 2020 | 15 | 0.040 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2020 | 16 | 0.040 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2020 | 17 | 0.040 |
Why?
|
| Amines | 1 | 2020 | 36 | 0.040 |
Why?
|
| Peru | 1 | 2020 | 47 | 0.040 |
Why?
|
| Models, Immunological | 1 | 2020 | 35 | 0.040 |
Why?
|
| History, Ancient | 1 | 2020 | 54 | 0.040 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2020 | 45 | 0.040 |
Why?
|
| Survival Rate | 2 | 2016 | 2035 | 0.040 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2020 | 7 | 0.040 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2020 | 7 | 0.040 |
Why?
|
| Cytidine Deaminase | 1 | 2020 | 31 | 0.040 |
Why?
|
| Herbivory | 1 | 2020 | 8 | 0.040 |
Why?
|
| Metabolism | 1 | 2020 | 42 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2022 | 327 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2020 | 55 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 174 | 0.040 |
Why?
|
| Protein Binding | 2 | 2019 | 1749 | 0.040 |
Why?
|
| Models, Statistical | 2 | 2014 | 471 | 0.040 |
Why?
|
| Neurons | 3 | 2016 | 1966 | 0.040 |
Why?
|
| Protein Isoforms | 2 | 2014 | 412 | 0.040 |
Why?
|
| Pseudogenes | 4 | 2004 | 53 | 0.040 |
Why?
|
| Africa | 1 | 2020 | 132 | 0.040 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2016 | 189 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2021 | 173 | 0.040 |
Why?
|
| Retroelements | 2 | 2014 | 41 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 307 | 0.040 |
Why?
|
| Bayes Theorem | 2 | 2011 | 283 | 0.040 |
Why?
|
| Mucopolysaccharidosis II | 2 | 1997 | 18 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2021 | 229 | 0.040 |
Why?
|
| Bacterial Proteins | 3 | 2010 | 887 | 0.040 |
Why?
|
| Genetic Vectors | 3 | 2012 | 940 | 0.040 |
Why?
|
| Sex Chromosomes | 2 | 2014 | 34 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 2 | 2014 | 147 | 0.040 |
Why?
|
| Epigenomics | 1 | 2021 | 164 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2020 | 256 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2021 | 271 | 0.040 |
Why?
|
| Independent Living | 1 | 2020 | 68 | 0.040 |
Why?
|
| Databases, Factual | 3 | 2019 | 1180 | 0.040 |
Why?
|
| RNA Splice Sites | 2 | 2014 | 87 | 0.040 |
Why?
|
| Visual Acuity | 2 | 2015 | 824 | 0.040 |
Why?
|
| Obesity | 1 | 2011 | 2278 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2016 | 4356 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2019 | 101 | 0.040 |
Why?
|
| Ecosystem | 1 | 2020 | 78 | 0.040 |
Why?
|
| Transplant Recipients | 1 | 2021 | 216 | 0.040 |
Why?
|
| Bacteriophage M13 | 2 | 1996 | 18 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 354 | 0.040 |
Why?
|
| CYS2-HIS2 Zinc Fingers | 1 | 2019 | 5 | 0.040 |
Why?
|
| Models, Animal | 2 | 2016 | 465 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 63 | 0.040 |
Why?
|
| Pigmentation | 1 | 2019 | 35 | 0.040 |
Why?
|
| Hybridization, Genetic | 1 | 2019 | 20 | 0.040 |
Why?
|
| Geography | 2 | 2010 | 110 | 0.040 |
Why?
|
| Plasmids | 3 | 2007 | 514 | 0.040 |
Why?
|
| Perception | 1 | 2020 | 220 | 0.040 |
Why?
|
| alpha-Galactosidase | 2 | 1997 | 20 | 0.040 |
Why?
|
| Ankyrins | 1 | 2020 | 99 | 0.040 |
Why?
|
| Peroxidases | 1 | 2019 | 26 | 0.040 |
Why?
|
| Language | 1 | 2020 | 204 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2021 | 541 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2021 | 412 | 0.040 |
Why?
|
| Genes, Homeobox | 1 | 2019 | 70 | 0.040 |
Why?
|
| Aotidae | 1 | 2018 | 3 | 0.040 |
Why?
|
| Drug Storage | 1 | 1998 | 17 | 0.040 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2020 | 174 | 0.040 |
Why?
|
| Firmicutes | 1 | 2018 | 21 | 0.040 |
Why?
|
| Pets | 1 | 2018 | 14 | 0.040 |
Why?
|
| Uterus | 1 | 2023 | 570 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2019 | 171 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2020 | 348 | 0.040 |
Why?
|
| Glutamine | 1 | 2020 | 211 | 0.040 |
Why?
|
| Ecotoxicology | 1 | 2018 | 2 | 0.040 |
Why?
|
| Geologic Sediments | 1 | 2018 | 5 | 0.040 |
Why?
|
| Templates, Genetic | 2 | 1996 | 97 | 0.040 |
Why?
|
| Computer Simulation | 2 | 2011 | 644 | 0.040 |
Why?
|
| Cytochrome P450 Family 4 | 1 | 2018 | 4 | 0.040 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2018 | 17 | 0.040 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 195 | 0.040 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2018 | 14 | 0.040 |
Why?
|
| Receptor, Notch2 | 1 | 2018 | 8 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2021 | 436 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 2018 | 39 | 0.040 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2018 | 16 | 0.040 |
Why?
|
| Moths | 1 | 2018 | 22 | 0.040 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2018 | 28 | 0.040 |
Why?
|
| Toxicity Tests | 1 | 2018 | 35 | 0.040 |
Why?
|
| Genomic Library | 2 | 1997 | 39 | 0.040 |
Why?
|
| Texas | 2 | 2017 | 3590 | 0.040 |
Why?
|
| Bifidobacterium | 1 | 2018 | 63 | 0.040 |
Why?
|
| Dopamine | 1 | 2020 | 286 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2019 | 428 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 62 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2016 | 3587 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2020 | 267 | 0.040 |
Why?
|
| Inflammation | 2 | 2018 | 1428 | 0.040 |
Why?
|
| Malassezia | 1 | 2017 | 7 | 0.040 |
Why?
|
| Saccharomyces | 1 | 2017 | 12 | 0.040 |
Why?
|
| Virulence | 2 | 2010 | 262 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2021 | 488 | 0.040 |
Why?
|
| DNA, Ribosomal Spacer | 1 | 2017 | 9 | 0.040 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2017 | 18 | 0.040 |
Why?
|
| Brain Stem | 1 | 2018 | 116 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2019 | 227 | 0.040 |
Why?
|
| Tissue Banks | 1 | 2018 | 26 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2020 | 370 | 0.040 |
Why?
|
| Infant Care | 1 | 2017 | 46 | 0.040 |
Why?
|
| Immunological Synapses | 1 | 2018 | 26 | 0.040 |
Why?
|
| Restriction Mapping | 3 | 1996 | 188 | 0.040 |
Why?
|
| Crustacea | 1 | 2017 | 4 | 0.040 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2017 | 12 | 0.040 |
Why?
|
| Cardiac Myosins | 1 | 2017 | 11 | 0.040 |
Why?
|
| Logistic Models | 2 | 2013 | 1810 | 0.040 |
Why?
|
| Copepoda | 1 | 2017 | 6 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2018 | 107 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2018 | 187 | 0.040 |
Why?
|
| Kallikreins | 1 | 2017 | 26 | 0.040 |
Why?
|
| Tropomyosin | 1 | 2017 | 26 | 0.040 |
Why?
|
| Heart Atria | 1 | 2020 | 316 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2018 | 122 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2018 | 73 | 0.040 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2018 | 68 | 0.040 |
Why?
|
| North America | 1 | 2018 | 240 | 0.040 |
Why?
|
| Epithelium | 1 | 2018 | 362 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2017 | 77 | 0.040 |
Why?
|
| Laminin | 1 | 2017 | 69 | 0.030 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2017 | 31 | 0.030 |
Why?
|
| Survival of Motor Neuron 2 Protein | 1 | 2017 | 13 | 0.030 |
Why?
|
| Candida | 1 | 2017 | 75 | 0.030 |
Why?
|
| Viremia | 1 | 2018 | 128 | 0.030 |
Why?
|
| Robotics | 1 | 1998 | 105 | 0.030 |
Why?
|
| Eye | 1 | 2018 | 227 | 0.030 |
Why?
|
| Gametogenesis | 1 | 2017 | 24 | 0.030 |
Why?
|
| Adenosine Diphosphate | 1 | 2017 | 60 | 0.030 |
Why?
|
| Philadelphia Chromosome | 1 | 2017 | 40 | 0.030 |
Why?
|
| Facial Paralysis | 1 | 2017 | 35 | 0.030 |
Why?
|
| Femur Neck | 1 | 2016 | 9 | 0.030 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 235 | 0.030 |
Why?
|
| Ketoglutaric Acids | 1 | 2016 | 24 | 0.030 |
Why?
|
| Trees | 1 | 2016 | 9 | 0.030 |
Why?
|
| CD56 Antigen | 1 | 2016 | 26 | 0.030 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2017 | 33 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2017 | 90 | 0.030 |
Why?
|
| Massachusetts | 1 | 2017 | 124 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2018 | 220 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2020 | 1495 | 0.030 |
Why?
|
| Antipsychotic Agents | 1 | 2020 | 373 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2018 | 263 | 0.030 |
Why?
|
| Amiloride | 1 | 2016 | 29 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 547 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2018 | 266 | 0.030 |
Why?
|
| Oryzias | 1 | 2016 | 9 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2018 | 144 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2016 | 30 | 0.030 |
Why?
|
| PAX2 Transcription Factor | 1 | 2016 | 27 | 0.030 |
Why?
|
| Epidemiologic Studies | 1 | 2016 | 43 | 0.030 |
Why?
|
| MEF2 Transcription Factors | 1 | 2016 | 42 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2018 | 211 | 0.030 |
Why?
|
| Decision Making | 2 | 2012 | 654 | 0.030 |
Why?
|
| Aldosterone | 1 | 2016 | 61 | 0.030 |
Why?
|
| Ocular Motility Disorders | 1 | 2017 | 38 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2020 | 317 | 0.030 |
Why?
|
| Pupa | 1 | 2016 | 21 | 0.030 |
Why?
|
| Ophthalmoplegia | 1 | 2017 | 54 | 0.030 |
Why?
|
| Phosphorus | 1 | 2017 | 56 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2018 | 173 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2017 | 98 | 0.030 |
Why?
|
| HIV | 1 | 2018 | 180 | 0.030 |
Why?
|
| Renin | 1 | 2016 | 94 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2022 | 747 | 0.030 |
Why?
|
| Magnesium | 1 | 2017 | 121 | 0.030 |
Why?
|
| Hypokalemia | 1 | 2016 | 41 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 151 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2019 | 309 | 0.030 |
Why?
|
| Cadherins | 1 | 2017 | 165 | 0.030 |
Why?
|
| National Human Genome Research Institute (U.S.) | 1 | 2016 | 17 | 0.030 |
Why?
|
| Pregnancy | 2 | 2020 | 7172 | 0.030 |
Why?
|
| Hydrochlorothiazide | 1 | 2016 | 71 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2016 | 80 | 0.030 |
Why?
|
| Triose-Phosphate Isomerase | 1 | 1996 | 5 | 0.030 |
Why?
|
| Diagnosis | 1 | 2016 | 29 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2016 | 17 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2017 | 250 | 0.030 |
Why?
|
| Virulence Factors | 1 | 2017 | 176 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2018 | 973 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 2017 | 103 | 0.030 |
Why?
|
| CD4 Antigens | 1 | 1996 | 56 | 0.030 |
Why?
|
| Autopsy | 1 | 2016 | 111 | 0.030 |
Why?
|
| Ampulla of Vater | 1 | 2016 | 16 | 0.030 |
Why?
|
| Wnt-5a Protein | 1 | 2016 | 21 | 0.030 |
Why?
|
| Synapses | 1 | 2020 | 459 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2016 | 200 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 2017 | 221 | 0.030 |
Why?
|
| Megakaryocytes | 1 | 2016 | 43 | 0.030 |
Why?
|
| Epinephrine | 1 | 2017 | 178 | 0.030 |
Why?
|
| Orbital Diseases | 1 | 2017 | 92 | 0.030 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2016 | 22 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2020 | 12342 | 0.030 |
Why?
|
| Data Mining | 1 | 2016 | 54 | 0.030 |
Why?
|
| Echinodermata | 1 | 2015 | 6 | 0.030 |
Why?
|
| Lysine | 1 | 2016 | 197 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 1285 | 0.030 |
Why?
|
| Genetic Drift | 1 | 2015 | 22 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 211 | 0.030 |
Why?
|
| Access to Information | 1 | 2016 | 40 | 0.030 |
Why?
|
| Cysteine | 1 | 2016 | 135 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 4430 | 0.030 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2015 | 8 | 0.030 |
Why?
|
| Myelin P0 Protein | 1 | 2015 | 25 | 0.030 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2015 | 15 | 0.030 |
Why?
|
| Myelin P2 Protein | 1 | 2015 | 9 | 0.030 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2015 | 21 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 1237 | 0.030 |
Why?
|
| Heterografts | 1 | 2016 | 177 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2016 | 51 | 0.030 |
Why?
|
| Milk, Human | 1 | 2018 | 301 | 0.030 |
Why?
|
| Suppression, Genetic | 1 | 2015 | 43 | 0.030 |
Why?
|
| Research Design | 2 | 2014 | 690 | 0.030 |
Why?
|
| Bee Venoms | 1 | 2015 | 7 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2017 | 423 | 0.030 |
Why?
|
| Gene Components | 1 | 2015 | 7 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2017 | 303 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 374 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2015 | 139 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 1425 | 0.030 |
Why?
|
| Time Factors | 2 | 2018 | 6309 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 776 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2018 | 385 | 0.030 |
Why?
|
| Fibrillins | 1 | 2015 | 31 | 0.030 |
Why?
|
| 5'-Nucleotidase | 1 | 2015 | 16 | 0.030 |
Why?
|
| Diploidy | 1 | 2015 | 35 | 0.030 |
Why?
|
| Lod Score | 1 | 2015 | 120 | 0.030 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2015 | 17 | 0.030 |
Why?
|
| Microscopy, Acoustic | 1 | 2015 | 17 | 0.030 |
Why?
|
| Ikaros Transcription Factor | 1 | 2015 | 28 | 0.030 |
Why?
|
| Physical Examination | 1 | 2016 | 162 | 0.030 |
Why?
|
| Penetrance | 1 | 2015 | 103 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2015 | 66 | 0.030 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2015 | 27 | 0.030 |
Why?
|
| Oligodendroglioma | 1 | 2014 | 24 | 0.030 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2014 | 8 | 0.030 |
Why?
|
| Protein Folding | 1 | 2016 | 218 | 0.030 |
Why?
|
| Fibrillin-1 | 1 | 2015 | 58 | 0.030 |
Why?
|
| Adaptation, Biological | 1 | 2015 | 33 | 0.030 |
Why?
|
| CREB-Binding Protein | 1 | 2015 | 63 | 0.030 |
Why?
|
| Minisatellite Repeats | 1 | 1995 | 43 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 459 | 0.030 |
Why?
|
| Scotoma | 1 | 2015 | 16 | 0.030 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2014 | 7 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 158 | 0.030 |
Why?
|
| Vitamin B 12 | 1 | 2015 | 55 | 0.030 |
Why?
|
| Proteolysis | 1 | 2015 | 169 | 0.030 |
Why?
|
| Replication Origin | 1 | 2014 | 11 | 0.030 |
Why?
|
| Sexual Behavior, Animal | 1 | 2015 | 87 | 0.030 |
Why?
|
| Clone Cells | 1 | 2015 | 168 | 0.030 |
Why?
|
| Motor Neurons | 1 | 2015 | 142 | 0.030 |
Why?
|
| Prostaglandins F | 1 | 2014 | 9 | 0.030 |
Why?
|
| Electroretinography | 1 | 2015 | 114 | 0.030 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2014 | 9 | 0.030 |
Why?
|
| Transcription Termination, Genetic | 1 | 2014 | 13 | 0.030 |
Why?
|
| Wool | 1 | 2014 | 3 | 0.030 |
Why?
|
| Keratins, Hair-Specific | 1 | 2014 | 3 | 0.030 |
Why?
|
| Spine | 1 | 2015 | 143 | 0.030 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type I | 1 | 2014 | 5 | 0.030 |
Why?
|
| DNA Polymerase III | 1 | 2014 | 27 | 0.030 |
Why?
|
| Vitamin B Complex | 1 | 2015 | 41 | 0.030 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2014 | 6 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2014 | 45 | 0.030 |
Why?
|
| Marsupialia | 1 | 2014 | 8 | 0.030 |
Why?
|
| Erdheim-Chester Disease | 1 | 2014 | 25 | 0.030 |
Why?
|
| Corneal Opacity | 1 | 2014 | 23 | 0.030 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2015 | 63 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2014 | 30 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2014 | 158 | 0.030 |
Why?
|
| Mice, Inbred CBA | 1 | 2014 | 31 | 0.030 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 1994 | 14 | 0.030 |
Why?
|
| Vision Tests | 1 | 2014 | 38 | 0.030 |
Why?
|
| Neutrophils | 1 | 2017 | 379 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2021 | 725 | 0.030 |
Why?
|
| Gastrulation | 1 | 2014 | 17 | 0.030 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2014 | 23 | 0.030 |
Why?
|
| Fatty Acids, Volatile | 1 | 2014 | 33 | 0.030 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2015 | 66 | 0.030 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2017 | 312 | 0.030 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 2014 | 31 | 0.030 |
Why?
|
| Radiography, Abdominal | 1 | 2014 | 47 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 95 | 0.030 |
Why?
|
| DNA Glycosylases | 1 | 1994 | 32 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 54 | 0.030 |
Why?
|
| Telomere Shortening | 1 | 2014 | 33 | 0.030 |
Why?
|
| Neurofibromin 1 | 1 | 2014 | 42 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 169 | 0.030 |
Why?
|
| Histiocytosis, Sinus | 1 | 2014 | 31 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 178 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2014 | 130 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 114 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2016 | 389 | 0.030 |
Why?
|
| Cerebrum | 1 | 2014 | 33 | 0.030 |
Why?
|
| Gene Editing | 1 | 2016 | 194 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 2142 | 0.030 |
Why?
|
| Coloboma | 1 | 2014 | 45 | 0.030 |
Why?
|
| Neurologic Manifestations | 1 | 2013 | 6 | 0.030 |
Why?
|
| Microphthalmos | 1 | 2014 | 60 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 359 | 0.030 |
Why?
|
| Hormones | 1 | 2014 | 187 | 0.030 |
Why?
|
| Population | 1 | 2013 | 21 | 0.030 |
Why?
|
| Disease Management | 1 | 2017 | 521 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2014 | 124 | 0.030 |
Why?
|
| Visual Fields | 1 | 2015 | 133 | 0.030 |
Why?
|
| Blindness, Cortical | 1 | 2013 | 15 | 0.030 |
Why?
|
| Reference Standards | 1 | 2014 | 238 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2016 | 185 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2008 | 136 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2016 | 262 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2014 | 137 | 0.030 |
Why?
|
| Hepatitis B virus | 1 | 2014 | 136 | 0.030 |
Why?
|
| Animals, Outbred Strains | 1 | 2013 | 13 | 0.030 |
Why?
|
| Abdomen | 1 | 2014 | 127 | 0.030 |
Why?
|
| Bile Acids and Salts | 1 | 2016 | 245 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 2014 | 121 | 0.030 |
Why?
|
| Population Control | 1 | 2013 | 4 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2014 | 177 | 0.030 |
Why?
|
| Caspase 8 | 1 | 2013 | 22 | 0.030 |
Why?
|
| Italy | 1 | 2013 | 113 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 121 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 487 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 886 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 457 | 0.030 |
Why?
|
| ADAMTS13 Protein | 1 | 2013 | 62 | 0.030 |
Why?
|
| Melopsittacus | 1 | 2012 | 7 | 0.030 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2013 | 27 | 0.030 |
Why?
|
| Proline | 1 | 2013 | 77 | 0.030 |
Why?
|
| Spermatogenesis | 1 | 2014 | 171 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2014 | 334 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 459 | 0.030 |
Why?
|
| Hepacivirus | 1 | 2014 | 242 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 1005 | 0.030 |
Why?
|
| NAV1.4 Voltage-Gated Sodium Channel | 1 | 2012 | 4 | 0.030 |
Why?
|
| Ampicillin Resistance | 1 | 2012 | 17 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2017 | 779 | 0.030 |
Why?
|
| Enzyme Stability | 1 | 2012 | 58 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2018 | 974 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2017 | 767 | 0.030 |
Why?
|
| Solubility | 1 | 2012 | 134 | 0.030 |
Why?
|
| Risk | 1 | 2014 | 757 | 0.030 |
Why?
|
| Serine | 1 | 2013 | 173 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2012 | 163 | 0.020 |
Why?
|
| Calcium Channels, L-Type | 1 | 2012 | 53 | 0.020 |
Why?
|
| Fetal Diseases | 1 | 2016 | 446 | 0.020 |
Why?
|
| Radiation Hybrid Mapping | 1 | 2012 | 6 | 0.020 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2014 | 136 | 0.020 |
Why?
|
| Chromosomes, Insect | 1 | 2012 | 7 | 0.020 |
Why?
|
| Cerebellum | 1 | 2016 | 416 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2012 | 49 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2012 | 144 | 0.020 |
Why?
|
| Recurrence | 1 | 2016 | 1425 | 0.020 |
Why?
|
| Machine Learning | 1 | 2015 | 242 | 0.020 |
Why?
|
| Mexico | 1 | 2012 | 180 | 0.020 |
Why?
|
| Starvation | 1 | 2012 | 15 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2014 | 319 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 543 | 0.020 |
Why?
|
| Critical Care | 1 | 2017 | 652 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2014 | 394 | 0.020 |
Why?
|
| Myocardium | 1 | 2017 | 1008 | 0.020 |
Why?
|
| Length of Stay | 1 | 2017 | 1309 | 0.020 |
Why?
|
| Triglycerides | 1 | 2014 | 573 | 0.020 |
Why?
|
| Saudi Arabia | 1 | 2011 | 38 | 0.020 |
Why?
|
| Protein Interaction Maps | 1 | 2012 | 78 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 141 | 0.020 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2011 | 20 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2014 | 409 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 258 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 1090 | 0.020 |
Why?
|
| Dacarbazine | 1 | 2011 | 86 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2013 | 809 | 0.020 |
Why?
|
| Twins, Dizygotic | 1 | 2011 | 42 | 0.020 |
Why?
|
| Linear Models | 1 | 2013 | 677 | 0.020 |
Why?
|
| Cerebrosides | 1 | 2011 | 4 | 0.020 |
Why?
|
| Australia | 1 | 2011 | 139 | 0.020 |
Why?
|
| Moloney murine leukemia virus | 1 | 1991 | 19 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 329 | 0.020 |
Why?
|
| Levodopa | 1 | 2011 | 91 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2014 | 539 | 0.020 |
Why?
|
| Helper Viruses | 1 | 1991 | 45 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 299 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1991 | 185 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1691 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2015 | 1192 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2011 | 212 | 0.020 |
Why?
|
| Papillomaviridae | 1 | 2011 | 137 | 0.020 |
Why?
|
| Photoreceptor Cells | 1 | 2011 | 91 | 0.020 |
Why?
|
| Rhabdoid Tumor | 1 | 2011 | 50 | 0.020 |
Why?
|
| Genome, Archaeal | 1 | 2010 | 7 | 0.020 |
Why?
|
| Tryptophan-tRNA Ligase | 1 | 1990 | 2 | 0.020 |
Why?
|
| Retroviridae | 1 | 1991 | 196 | 0.020 |
Why?
|
| Solutions | 1 | 2010 | 65 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 199 | 0.020 |
Why?
|
| Peptide Termination Factors | 1 | 1990 | 16 | 0.020 |
Why?
|
| Urogenital System | 1 | 2010 | 34 | 0.020 |
Why?
|
| Wasp Venoms | 1 | 2010 | 3 | 0.020 |
Why?
|
| Insect Viruses | 1 | 2010 | 9 | 0.020 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 1990 | 26 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2011 | 1066 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 1252 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2005 | 296 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 1028 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2015 | 523 | 0.020 |
Why?
|
| Mouth | 1 | 2010 | 61 | 0.020 |
Why?
|
| Respiratory System | 1 | 2010 | 96 | 0.020 |
Why?
|
| Ornithine Carbamoyltransferase | 1 | 1989 | 17 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 1196 | 0.020 |
Why?
|
| Wolbachia | 1 | 2010 | 44 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2012 | 605 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2011 | 284 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2014 | 930 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1989 | 120 | 0.020 |
Why?
|
| Animals, Domestic | 1 | 2009 | 31 | 0.020 |
Why?
|
| Hexokinase | 1 | 1989 | 20 | 0.020 |
Why?
|
| Ciliary Body | 1 | 2009 | 31 | 0.020 |
Why?
|
| Locus Control Region | 1 | 2008 | 8 | 0.020 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2008 | 16 | 0.020 |
Why?
|
| Uveitis | 1 | 2009 | 36 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 356 | 0.020 |
Why?
|
| Proto-Oncogenes | 1 | 2008 | 37 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1989 | 89 | 0.020 |
Why?
|
| Vagina | 1 | 2010 | 196 | 0.020 |
Why?
|
| Fusidic Acid | 1 | 2008 | 4 | 0.020 |
Why?
|
| Deoxyuracil Nucleotides | 1 | 2008 | 6 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2008 | 93 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2008 | 37 | 0.020 |
Why?
|
| RNA Nucleotidyltransferases | 1 | 2008 | 34 | 0.020 |
Why?
|
| RNA, Small Untranslated | 1 | 2008 | 21 | 0.020 |
Why?
|
| Operon | 1 | 2008 | 52 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 2008 | 43 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 66 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2011 | 677 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 667 | 0.020 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 1988 | 14 | 0.020 |
Why?
|
| Karyotyping | 1 | 2008 | 331 | 0.020 |
Why?
|
| Growth and Development | 1 | 2008 | 22 | 0.020 |
Why?
|
| Individuality | 1 | 2008 | 34 | 0.020 |
Why?
|
| Europe | 1 | 2009 | 354 | 0.020 |
Why?
|
| Taste | 1 | 2008 | 31 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 2090 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2009 | 160 | 0.020 |
Why?
|
| Edar Receptor | 1 | 2007 | 9 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2011 | 334 | 0.020 |
Why?
|
| Genomic Islands | 1 | 2007 | 29 | 0.020 |
Why?
|
| Oogenesis | 1 | 2008 | 56 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2008 | 184 | 0.020 |
Why?
|
| RNA Stability | 1 | 2008 | 84 | 0.020 |
Why?
|
| Antiporters | 1 | 2007 | 32 | 0.020 |
Why?
|
| Spores, Bacterial | 1 | 2007 | 23 | 0.020 |
Why?
|
| Gamma Rays | 1 | 2007 | 49 | 0.020 |
Why?
|
| Rifampin | 1 | 2008 | 129 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2007 | 135 | 0.020 |
Why?
|
| Biofilms | 1 | 2008 | 92 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 619 | 0.020 |
Why?
|
| Hydrolases | 1 | 2007 | 58 | 0.020 |
Why?
|
| BRCA1 Protein | 1 | 2007 | 69 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2008 | 147 | 0.020 |
Why?
|
| Methicillin Resistance | 1 | 2007 | 118 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2007 | 155 | 0.020 |
Why?
|
| Kidney | 1 | 2014 | 1354 | 0.020 |
Why?
|
| Haemophilus ducreyi | 1 | 2006 | 2 | 0.020 |
Why?
|
| Actinobacillus pleuropneumoniae | 1 | 2006 | 2 | 0.020 |
Why?
|
| Oligonucleotide Probes | 3 | 1991 | 85 | 0.020 |
Why?
|
| Calcification, Physiologic | 1 | 2006 | 22 | 0.020 |
Why?
|
| Prophages | 1 | 2006 | 6 | 0.020 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2006 | 17 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2007 | 203 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2007 | 238 | 0.020 |
Why?
|
| Complement Activation | 1 | 2006 | 52 | 0.020 |
Why?
|
| China | 1 | 2007 | 245 | 0.020 |
Why?
|
| Monocytes | 1 | 2008 | 354 | 0.020 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2006 | 19 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 2 | 2008 | 2424 | 0.020 |
Why?
|
| Smoking | 1 | 2011 | 1044 | 0.020 |
Why?
|
| Hippocampus | 1 | 2011 | 830 | 0.020 |
Why?
|
| DNA, Ribosomal | 1 | 2005 | 55 | 0.020 |
Why?
|
| Eukaryotic Cells | 1 | 2005 | 31 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2006 | 174 | 0.020 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2005 | 59 | 0.020 |
Why?
|
| Frameshifting, Ribosomal | 1 | 2004 | 3 | 0.010 |
Why?
|
| Rickettsia conorii | 1 | 2004 | 4 | 0.010 |
Why?
|
| Genes, rRNA | 1 | 2004 | 19 | 0.010 |
Why?
|
| Electron Transport Complex IV | 1 | 2004 | 39 | 0.010 |
Why?
|
| Rickettsia | 1 | 2004 | 13 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 2004 | 125 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2005 | 321 | 0.010 |
Why?
|
| Histones | 1 | 2007 | 535 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 1461 | 0.010 |
Why?
|
| DNA, Protozoan | 1 | 2003 | 31 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2005 | 383 | 0.010 |
Why?
|
| Glass | 1 | 2002 | 12 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2007 | 807 | 0.010 |
Why?
|
| Microspheres | 1 | 2002 | 71 | 0.010 |
Why?
|
| Transfection | 2 | 1997 | 1069 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 3435 | 0.010 |
Why?
|
| Cell Movement | 1 | 2005 | 835 | 0.010 |
Why?
|
| GC Rich Sequence | 1 | 2001 | 6 | 0.010 |
Why?
|
| Public Sector | 1 | 2001 | 13 | 0.010 |
Why?
|
| Private Sector | 1 | 2001 | 24 | 0.010 |
Why?
|
| Drug Industry | 1 | 2001 | 46 | 0.010 |
Why?
|
| Cricetulus | 2 | 1991 | 97 | 0.010 |
Why?
|
| Cricetinae | 2 | 1991 | 414 | 0.010 |
Why?
|
| Heterochromatin | 1 | 2000 | 49 | 0.010 |
Why?
|
| Forecasting | 1 | 2001 | 352 | 0.010 |
Why?
|
| Biological Transport | 1 | 2000 | 348 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1997 | 46 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1997 | 46 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2002 | 2410 | 0.010 |
Why?
|
| Glycolysis | 1 | 1997 | 148 | 0.010 |
Why?
|
| Chromosome Walking | 1 | 1995 | 8 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1995 | 41 | 0.010 |
Why?
|
| Fabry Disease | 1 | 1995 | 17 | 0.010 |
Why?
|
| Swine | 2 | 1989 | 1173 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 1996 | 223 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1996 | 480 | 0.010 |
Why?
|
| Uracil-DNA Glycosidase | 1 | 1994 | 5 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 1393 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1991 | 163 | 0.010 |
Why?
|
| Meiosis | 1 | 1991 | 115 | 0.010 |
Why?
|
| Adenosine Deaminase | 1 | 1991 | 74 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1991 | 215 | 0.010 |
Why?
|
| Poly A | 1 | 1990 | 59 | 0.010 |
Why?
|
| Codon | 1 | 1989 | 97 | 0.010 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1989 | 79 | 0.000 |
Why?
|
| DNA Probes | 1 | 1989 | 124 | 0.000 |
Why?
|
| Rabbits | 1 | 1990 | 711 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1989 | 315 | 0.000 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 1988 | 22 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1988 | 100 | 0.000 |
Why?
|
| Mice, Inbred ICR | 1 | 1988 | 153 | 0.000 |
Why?
|
| Mice, Mutant Strains | 1 | 1988 | 384 | 0.000 |
Why?
|